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ABSTRACT
Rheumatoid arthritis (RA) is an autoimmune disease affecting nearly 1% of the world’s
population with symptoms such as inflammation, pain, and reduced strength [1]. Physicians and
scientists work to develop pharmaceuticals and medical devices aimed at decreasing the
symptoms associated with RA to better the lives of those affected. One of the most recent
developments is the addition of thermal therapy gloves to the array of upper limb orthoses
available to patients with RA. It was hypothesized that this study will show that orthoses in the
form of thermal therapy gloves are beneficial to the patients by reducing symptoms such as pain
and allowing them an increased range of motion and overall hand functionality. Patients in stage
2 were recruited and asked to first complete a personal history survey including the Health
Assessment Questionnaire (HAQ) [2] and Pain Catastrophizing Scale (PCS) [3]. Range of
motion tasks and the Arthritis Hand Function Test (AHFT) [4] were completed to determine the
effect of two thermal therapy gloves on the range of motion and activities of daily living. The
data suggests that the use of thermal therapy orthoses does provide a psychological advantage in
the form of reduced perceived pain along with the advantage of being able to complete activities
previously believed to be impossible for participants to complete. Additionally, it is suggested
that heat-generating material be used in the manufacturing of these orthoses in order to remove
the need for any further design modifications. Future studies should be conducted in order to
analyze the long-term effects of these orthoses along with the possible psychological benefits of
their use.

xii

CHAPTER 1: INTRODUCTION

1.1 Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune disease that affects close to 1% of the
world’s population. RA symptoms include inflammation, pain, and reduced strength therefore
reducing the quality of life of the patient [1]. There is very little clinical evidence supporting the
use of non-pharmaceutical treatments for patients suffering from RA. This pilot study aims to
provide useful information on orthotic treatments for patients suffering from RA in their hands
and wrists.
1.2 Gap in Knowledge
Rheumatoid Arthritis (RA) is a very common disease, affecting close to 2 million people
in the United States alone [5]. Physicians and scientists work to develop pharmaceuticals and
medical devices aimed at decreasing the symptoms associated with RA to better the lives of
those affected. One of the most recent developments is the addition of thermal therapy gloves to
the array of upper limb orthoses available to patients with RA. These gloves have been widely
accepted by patients but have very little scientific evidence supporting the claims of
manufacturers. In a literature review recently published by the author, the effectiveness of upperlimb orthoses used in RA was evaluated to assess the overall use of orthoses compared to
traditional interventions [6]. The intent of this pilot study is to determine the effectiveness of two
different thermal therapy gloves on the symptoms of rheumatoid arthritis.
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1.3 Importance of Range of Motion
Maintaining a somewhat normal range of motion (ROM) is critical in order to prevent the
decrease in hand function and the overall quality of life for the patient. ROM is directly linked to
hand function performance and being able to carry out activities of daily living independently
[7]. Due to the importance of these factors, an array of ROM tests are performed in this pilot
study in order to accurately address the correlation between a patient’s ROM and their capacity
to complete certain activities of daily living.
1.4 Importance of Performing Daily Activities
Activities of daily living (ADL) such as buttoning a shirt, tying a shoelace, or pouring a
glass of water can be very strenuous for patients with diseases such as rheumatoid arthritis. The
ability to perform ADLs is linked to the overall independence of the patient and their quality of
life [7]. ADLs were tested in this study by performing the Arthritis Hand Function Test and
measuring the capabilities of each patient.
1.5 Hypothesis
It is hypothesized that this study will show that orthoses in the form of thermal therapy
gloves are beneficial to the patients by reducing symptoms such as pain and allowing them an
increased range of motion and overall hand functionality.

2

1.6 Specific Aims and Objectives
Aim 1: Determine if each thermal therapy arthritic glove increases range of motion [8, 9] in
patients by comparing the performance with and without the gloves
Aim 2: Determine if each thermal therapy arthritic glove decreases the amount of pain
experienced by the patient when completing specific tasks using the Rheumatoid Arthritis Pain
Scale [10].
Aim 3: Determine if each thermal therapy arthritic glove increases hand strength, dexterity and
overall function using the Arthritis Hand Function Test [4].
Aim 4: Determine the advantages and disadvantages of each thermal therapy arthritic glove by
comparing the results of each test.

3

CHAPTER 2: BACKGROUND

2.1 Rheumatoid Arthritis
2.1.1 Overview
Rheumatoid arthritis, one of the most common forms of arthritis, is a chronic
inflammatory disease affecting joints. The most common joints affected are the proximal
interphalangeal joints, metacarpophalangeal joints, wrists, knees, ankles, and toes [5]. The
worldwide prevalence of RA is 0.5-1% in developed countries [5]. Within the United States, the
current prevalence of RA is as high as 0.6% [5] affecting nearly 1.5 million people [11].
Typically, the onset of the disease occurs between 30-60 years of age [14] and women are
diagnosed three times as often as men [12]. The severity of RA and how it affects the patient
varies; allowing some individuals to carry out their normal life while others are disabled within
years of the initial diagnosis. Of those patients who were working at the time of the diagnosis,
20-70% were disabled and no longer able to work after 7-10 years [13].
2.1.2 Causes
Although the single root cause of RA is unknown, studies have shown that factors such as
environment, hormones, and genetics play a large role [14]. In addition to genetic causes, studies
show that physical trauma can also lead to the onset of RA [15]. These factors trigger a reaction
of the immune system which leads to the development of the disease [16].
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2.1.3 Symptoms
Patients with RA experience a variety of symptoms that can range from being
manageable to debilitating. Forty percent of early RA patients have swelling in their finger
joints, mainly the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints. This
then leads to the hand and wrist being affected within four months of the initial swelling [17]. In
long standing RA patients, the hand is affected in 85% of all patients and ulnar deviations at the
MCP joints are found in 45% of all patients [17]. Other symptoms include pain, stiffness,
tenderness, deformed joints, Carpal Tunnel syndrome, and fatigue [17]. Patients experience a
decrease in their ability to complete activities of daily living (ADL) because of these symptoms
and with that, a decline in their overall quality of life.
2.1.4 Diagnosis
Rheumatoid arthritis is defined using classification criteria in order to properly diagnose
and treat those with and without RA. Historically, patients showing symptoms of RA have been
difficult to definitively diagnose as having RA due to the varying range of classifications used by
physicians. The most commonly used set of criterion was previously created in 1987 by the
American College of Rheumatology [18]. These criteria were well accepted but contained
limitations that hindered diagnosis and consequently, treatment. Therefore, in 2008 the American
College of Rheumatology and the European League Against Rheumatism began developing new
classification criteria for RA. The new system uses weighted classifications on a scoring system
to quantify the symptoms of each patient and relate the score to the severity and diagnosis of
rheumatoid arthritis. These new criteria allow for much more specific classifications and much
earlier diagnoses [18].
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For the purpose of this study, stages were classified based on the extent of cartilage and
bone damage as seen via traditional x-rays [19]. Since the new classification criteria developed
by the American College of Rheumatology and the European League Against Rheumatism
moves away from specific levels of the disease and more towards a case by case treatment, it was
decided to classify subjects based on traditional stages using x-rays for the purpose of grouping
and analysis. The classification studied were participants with stage 2; cartilage damage [19].
Stage 1 participants were not included in this study because patients in stage 1 have early stage
cartilage damage and typically do not require as much treatment as those in stage 2 or stage 3
[19]. Similarly, patients classified as stage 4 were not included because the extent of the bone
erosion and cartilage damage is too great to benefit from orthoses [19]. Patients categorized as
stage 3 should be included in future studies.
2.1.5 Treatments
Patients with rheumatoid arthritis (RA) suffer from symptoms such as pain, loss of
function, and joint damage. Treatments aim to prevent these and other symptoms from occurring
through the use of pharmaceuticals, exercises, assistive devices, or other types of therapies [20].
The rheumatoid arthritis pharmaceutical industry is a multibillion-dollar industry with 10 large
companies dominating the market [21]. These medications are disease-modifying antirheumatic
drugs (DMARDs), corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) [22]. In
addition to pharmacologic interventions, treatments such as exercise, joint protection, assistive
technology, thermotherapy, dieting, and occupational or physical therapy are widely used by
patients suffering from RA [11, 20, 23]. Additionally, copper is sometimes used to treat RA both
intravenously [24] and when manufactured into clothes, jewelry or orthoses [25]. As a last resort,
surgical interventions such as arthroplasty and joint replacement can be performed to help treat
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the symptoms of RA [26]. However, only 315,000, 21%, of patients typically receive surgical
interventions as compared to the 1.5 million Americans living with the disease [26].
2.2 Orthoses
2.2.1 Static
Static resting splints are the most common orthosis used to treat rheumatoid arthritis
(RA). These orthoses hold the metacarpal joints in a slight flexion in order to place the hand in
the ideal anatomical position to reduce swelling, improve hand function, and prevent deformity
[17]. Static resting splints have been around since the early 1900’s and have been used for postoperative care [27]. Although shown to decrease symptoms such as morning stiffness [17], static
orthoses significantly decrease range of motion (ROM) to the point of patients no longer being
able to use the affected hand when completing ADLs. Additionally, a recent study found no
significant change in grip strength of individuals using static orthoses over the course of a year
[17].
2.2.1.1 Current Research in Static Orthoses
Static orthoses are used to immobilize the affected appendage or joint, such as the hand
and wrist, in order to reduce the swelling and pain. By immobilizing the joints, there is a
decrease of friction and temperature which also decreases the symptoms commonly felt by
patients [17]. However, these static orthoses severely reduce the independence of the user
depending upon the extent of immobility. Previous studies show that over an extended period of
time, static orthoses aid in decreasing the symptoms of RA. Yet these studies also disclose that
the decrease is not statistically significant in addition to the uncertainty of whether or not patients
were actually wearing the orthoses for the desired amount each day [1, 28].
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2.2.2 Dynamic
Dynamic hand-wrist orthoses allow for patients to maintain a proper anatomic position
while having the opportunity to maintain limited range of motion. Similar to static orthoses,
dynamic orthoses have been around since the 1900’s and were originally used for post-operative
patient care [27]. Orthoses of this type are used to assist individuals who are unable to make a
functional grasp, however, they are generally used for stroke patients where paralysis, not pain,
is the limiting factor [29]. When using a dynamic orthosis, a patient must use their own muscles
to begin the motion while the orthosis aids in motion stability [30]. This is often painful for
patients suffering from RA as they may not have the force required to begin the movement of the
orthosis [30]. However, these orthoses allow for the hand and wrist to remain in the anatomically
correct position [30]. For this reason, typical dynamic orthoses provide no more advantage than
static orthoses, which is why this study looked at a different form of dynamic orthoses.
2.2.2.1 Current Research in Dynamic Orthoses
Dynamic hand-wrist orthoses are used to assist individuals who are unable to make a
functional grasp. Although RA patients do use dynamic orthosis to potentially aid in the relief of
symptoms, they are typically used on stroke patients where paralysis, not pain, is the limiting
factor [29]. For this reason, there is a lack of studies looking at the effects of a traditional
dynamic hand wrist orthosis on RA patients.
2.2.3 Powered
Powered orthoses and prostheses have been around since the 1940’s, correlating with the
invention of the powered tools. From their inception as an aid to factory workers with amputated
limbs, powered orthoses have been focused on rehabilitation and quality of life improvement
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[31]. Powered orthoses are used by patients who do not have the ability to perform simple hand
functions on their own [31]. For patients with severe RA, these orthoses allow them to regain a
level of independence that may have been previously lost due to their condition. According to
Pawel Maciejasz, who conducted a recent survey on robotic devices for upper limb
rehabilitation, there is a significant need for powered hand wrist orthoses to aid users in
rehabilitation and completing daily activities, but few of such devices have been proposed.
Maciejasz found that there are no orthoses that would allow for the wide range of wrist and
finger motion similar to those that dynamic orthoses provide the user. Some of the biggest
drawbacks to any powered hand orthosis are cost, weight, portability, and charge/battery life. A
powered hand orthosis is designed to help in activity completion meaning it will need to support
movement of multiple joints. This support is gained by the installment and use of actuators
and/or other necessary parts, which increases the overall cost and weight of the orthosis and
makes it less portable. Additionally, the amount of available energy is limited to storage capacity
[32].
2.2.3.1 Current Research in Powered Orthoses
The W-EXOS is a powered orthosis that assists with forearm and wrist motion through
electromyography (EMG) based fuzzy-neuro control. This fuzzy-neuro control method
implements fuzzy if-then rules to determine the required torque to the motor, according to the
intended motion, to ultimately obtain natural and flexible motion assist. The main drawback of
this type of a powered orthosis is the control method working universally; difficulty in defining
the fuzzy if-then logic that is applied to devices with higher degrees of freedom cause some
motions to be unnatural and inflexible [33].
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The active support splint driven by soft pneumatic actuator (ASSIST) helps assist
individuals with wrist bending motion. When the ASSIST is in its initial state the wrist is in a
relaxed position, and when the ASSIST is in a pressurized state wrist flexion is achieved. The
ASSIST has been effective in decreasing muscle fatigue but was unclear in whether it increased
muscle strength and/or whether it is effective in decreasing pain when assisting the user in
completing tasks [34].
After gathering information on the use and different types of powered orthoses, it was
determined that these orthoses were not as frequently used by patients with RA because of the
apparent reduction of independence and the bulk of the assistive technology. Therefore, an
alternative type of dynamic orthoses, thermal therapy gloves, were chosen to be included in this
study.
2.2.4 Thermal Therapy Gloves
Thermal therapy gloves are widely recommended by occupational therapists to patients
with rheumatoid arthritis for the purpose of decreasing pain and allowing the patient to have
more use of the affected hand and wrist. Although different forms of these gloves have been in
use since the 1970’s, there is little evidence supporting their effectiveness [35].
These orthoses are much less bulky than the traditional static orthoses or the possibly
painful dynamic orthoses typically used by RA patients to alleviate stress on their joints.
Additionally, these gloves allow the patient to maintain a level of independence by granting them
a class of range of motion that traditional orthoses hinder [35].
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2.2.4.1 Current Research in Thermal Therapy Gloves
There is a scarce amount of research previously conducted with regards to thermal
therapy gloves. Siti Hana Nasir, Olga Troynikov and Nicola Massy-Westropp conducted a
literature review in 2014 where eight studies were reviewed and seven outcome measures
evaluated in order to determine the “effects of wearing therapy gloves on patients’ hand function
and symptoms” [35]. This literature review looked at hand pain, stiffness, swelling, grip strength
and overall function as some of the outcome measures however, it was found that there was
marginal or no improvement in hand function when using thermal therapy gloves. Pain, stiffness,
swelling and grip strength did improve with the use of these gloves. This literature review
suggests further research aiming at quantifying the effectiveness of therapy gloves in regards to
hand function and glove performance.
Recently, the Centre for Health Sciences Research at the University of Salford conducted
a study comparing the effectiveness of compression gloves at night for patients with rheumatoid
arthritis and hand osteoarthritis. This study reported a significant reduction in finger joint
swelling in rheumatoid arthritis patients however, the study was deemed inconclusive due to
unsatisfactory data reporting. This study, conducted in early 2016, highlights the need for
additional investigation into the effectiveness of therapy gloves [36].
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CHAPTER 3: METHODOLOGY

This randomized control trial included patients classified as having stage 2 Rheumatoid
Arthritis, who were asked to perform specific ranges of motion and activities of daily living four
separate times; once without the aid of an orthosis (control), once with a placebo orthosis, once
with the first thermal therapy glove, and once with the second thermal therapy glove.
3.1 Inclusion/Exclusion Criteria
Patients must have been able to understand the informed consent form and suffer from
diagnosed rheumatoid arthritis in their hands. Patients must have been at least eighteen years old
and able to follow directed activities. A total of five patients were included in this study, all
categorized as stage 2.
The different stages of RA were classified based on the traditional categorizations
determined by X-ray and ultrasound screenings. A patient was considered to be in stage 1 if they
had inflammation in the joint capsule and swelling of the synovial tissue surrounding the area but
they did not have any permanent damage or deterioration. Stage 2 was if the inflammation of the
synovial tissue causes cartilage damage but there was no bone deterioration. A patient was
considered to be in stage 3 if the inflammation had caused both cartilage damage and bone
deterioration. The final stage, stage 4, was when the inflammatory process ends and the joints
were fused together, causing them to stop working completely [37].
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3.2 Patient History Survey (See Appendix A)
3.2.1 General History Questions
General information was collected from each subject such as age, gender, and year of
diagnosis. This information was collected for the purpose of analyzing results based on factors
such as gender and if the patient had ever used an orthosis for their RA.
3.2.2 Health Assessment Questionnaire
The Health Assessment Questionnaire (HAQ), developed by Stanford University, was
developed to gather information on the quality of life of patients living with a disease or
impairment [2]. The HAQ used in this study was based off of the original Stanford HAQ and was
used to evaluate the limitations of the patient during their daily life. Sample questions were:
•

When you wake up in the morning, do you ache?

____ Y ____ N

o If yes, how long does your pain last? _____ hours _____ minutes
•

I exercise ___ daily ___ weekly ___ monthly

•

I ___ walk ___ do yoga ___ water exercises ___ garden ___ dance ______ other

3.2.3 Pain Catastrophizing Scale
Included in the patient history survey was the Pain Catastrophizing Scale (PCS) (Table
1), developed and validated by Michael JL Sullivan in 1995. The Pain Catastrophizing Scale
(PCS) was developed in order to measure the psychological effect of pain and the “mechanisms
by which catastrophizing impacts on pain experience” [3]. This scale gives information on the
patient’s mentality towards their pain and can be used to shed light on clustered results (i.e. if
results are in two clusters, one may have a high PCS score and the other may have a low PCS
score).
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Table 1: Pain Catastrophizing Scale Questions [3]
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

I worry all the time about whether the pain will end
I feel I can’t go on
It’s terrible and I think it’s never going to get any better
It’s awful and I feel that it overwhelms me
I feel I can’t stand it anymore
I become afraid that the pain will get worse
I keep thinking of other painful events
I anxiously want the pain to go away
I can’t seem to keep it out of my mind
I keep thinking about how much it hurts
I keep thinking about how badly I want the pain to stop
There’s nothing I can do to reduce the intensity of the pain
I wonder whether something serious may happen

3.3 Arthritis Hand Function Test (See Appendix B)
3.3.1 Purpose
The Arthritis Hand Function Test (AHFT) was created to aid therapists in evaluating the
strength and dexterity of patients with osteoarthritis and rheumatoid arthritis [4]. The test covers
strength, applied strength, dexterity, and applied dexterity by completing the following tasks:
Table 2: Arthritis Hand Function Test [4]
Strength
Applied Strength
Dexterity

Grip and Pinch Strength
Pouring Water
Pegboard
Shoe Lacing, Button Board, Safety Pins,
Eating Utensils, Coin Pick-Up

Applied Dexterity

These specific tasks provided insight into general activities of daily living and how well
the patient is able to perform them.
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3.3.2 Overview
Each patient participated in The Arthritis Hand Function Test which measured their hand
strength, dexterity, and overall hand function. Each participant repeated the test four times: first,
without any orthosis; second, with the placebo glove; third, with the IMAK Compression
Arthritis Gloves; and fourth, with the Veturo Infrared Therapy Gloves. The order of these trials
was randomized for each subject. The measurements taken during this test included but were not
limited to grip and pinch strength, pegboard dexterity, manipulating coins, and pouring a glass of
water [4]. The scores of the test were compared to a Hand Function Profile sheet appropriate for
the age and sex of the patient, which provided the normal measurements for each test [4].
The Arthritis Hand Function Test was chosen because it was specifically tested and
designed for patients with rheumatoid arthritis and has been proven to be a valid and reliable
testing method [4, 38]. The AHFT was chosen over similar tests, such as the Jebsen Hand
Function Test or the Michigan Hand Outcomes Questionnaire [39], because it is specific to
arthritis and has been validated using patients with rheumatoid arthritis. Other hand function
tests, although similar, are not specific to RA.
3.4 Range of Motion Tasks (See Appendix C)
3.4.1 Purpose
One of the more severe symptoms of RA is the reduction of the range of motion of the
affected joints, limiting the activities of daily living a person can complete [17]. Although
activities of daily living were tested using the Arthritis Hand Function Test (AHFT), including
specific range of motion exercises allowed for a broader view of the abilities of each patient
outside of the specific tasks being performed in the AHFT.
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3.4.2 Overview
When assessing range of motion each patient performed specific, measured movements
first without the aid of any orthoses and then with each of the gloves, giving a total of four sets
of range of motion data (i.e. “Range of Motion without Orthosis”, “Range of Motion with
IMAK”, etc.). Additionally, each data set was broken down into two subsets; fingers and
thumbs. During each data set patients were asked to perform simple range of motion movements
to the best of their ability. The measurements of the fingers subset were [9]:
•

Metacarpophalangeal Flexion and Extension

•

Proximal Interphalangeal Flexion and Extension

The measurements of the thumb subset were [9]:
•

Carpometacarpal Abduction and Adduction

•

Metacarpophalangeal Flexion and Extension

Motion capture was used to measure these range of motion tests as it is more precise than using a
goniometer and has a smaller error rate.
The ranges of motion being tested were chosen because they are specific to the joints
affected by rheumatoid arthritis. The metacarpophalangeal joints, and proximal interphalangeal
joints are affected whereas the distal interphalangeal joint is not affected by RA and was
therefore not included in the range of motion tasks being studied [40].
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3.5 Rheumatoid Arthritis Pain Scale
3.5.1 Purpose
The Rheumatoid Arthritis Pain Scale (RAPS) is an adaptation from the Likert Scale and
was developed to create a clinical instrument for measuring the symptom of pain in adults with
RA [41]. The RAPS is widely used and has been clinically validated to warrant more use [42].
3.5.2 Overview
In order to establish a baseline for each patient, all data collection periods began with the
patient rating their current level of pain based on the Rheumatoid Arthritis Pain Scale (RAPS).
Patients were asked to continuously rate the level of pain being experienced throughout the data
collection period and during each individual task or movement.

Figure 1: Rheumatoid Arthritis Pain Scale (RAPS) [41]
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The Rheumatoid Arthritis Pain Scale (RAPS) is a Visual Analogue Scale and was chosen
because it was developed and tested specifically for patients suffering from RA by Stanford
University and is based off the common Likert Scale [10].
As opposed to other common pain scales used in the medical field, the RAPS has been
adapted specifically for patients with rheumatoid arthritis. Other common validated scales, such
as the Wong-Baker Facial Pain Scale and the McGill Pain Questionnaire (MPQ), are either
specified to other groups, such as pediatric for the Wong-Baker Facial Scale, or are too general,
as with the MPQ [43, 44, 45]. These pain scales may result in similar results for this study,
however, it was determined that the RAPS would be most applicable due to the specialization of
rheumatoid arthritis.
3.6 Additional Outcome Measures
Additional outcome measures collected were the oxygen saturation of the blood and
surface temperature of the subjects’ hands. These were collected using a pulse oximeter [46] and
laser thermometer [47] respectively. The oxygen saturation and surface temperature were taken
after each task (i.e. after each range of motion task, after each task within the Arthritis Hand
Function Test). The blood oxygen saturation and surface temperature were collected because an
increase in both was crucial to the arthritis gloves aiding symptoms such as pain and swelling
[35].
3.7 Kinematic Motion Capture and Analysis
The range of motion exercises were measured using the combination of a motion capture
system, Vicon Nexus, and biomechanics analysis software, C-Motion Visual 3D.
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3.7.1 Vicon Motion Capture System
The Vicon Motion Capture system used to collect kinematic range of motion data utilizes
an 8-camera 3D set-up, this allows for a 3D global coordinate system to be estimated from
multiple 2D views. Direct linear transformation is used which assumes a linear relationship
between the 2D camera coordinates and the 3D coordinates of a marker. There are three different
Cartesian coordinate systems required to successfully capture motion; the Global Coordinate
System (GCS), Local Coordinate System (LCS), and the Force Platform Coordinate System
(FCS). An important assumption regarding all of these systems is that of rigidity, although
anatomically incorrect, it is crucial when defining body segments [48].
The GCS is the capture volume where the 3D space of the motion capture system is
represented. All recorded data are logged into this system when using the Vicon Motion Capture
System. This coordinate system is a right-handed orthogonal system with the vertical direction
being the most important to define because of subject movement. The assumption of rigidity
allows for segments to be effectively defined by an LCS which moves with the segment. Like the
GCS, the LCS is a right-handed orthogonal system. The orientation of the LCS with respect to
the GCS defines the orientation of a segment. In other words, as an object moves in the GSC, the
endpoints move in the LCS and the transformation between the two systems allow for the linear
and rotational description of movement [48].
In order to define a segment within the LCS 3 non-collinear points are required. The
placement of these points, or markers, is used to establish the LCS and typically the XYZ axes
are assigned posteriorly, anteriorly, and superiorly respectively. When creating segments, joint
constraints are added in order to minimize the effect of soft tissue and measurement error. The
system then searches for the optimal pose in each frame that allows for the minimum difference
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between the measured and model-determined marker coordinates. This process allows for
variability in the number of markers and marker segments based on the desired model output and
the kinematics being studied [48].
A benefit to using this specific system is that if there are missing markers in a frame, a lot
of noise, or false markers, the segment and model can still be observable because of the joint
constraints previously placed. The inclusion of these joint constraints minimizes soft tissue
artifact and reduces the amount of noise and overall error during a study. A disadvantage of this
system is analogous in that with the amount of extrapolation required of the system to replace a
missing point in numerous frames, this then adds to the general error of each trial or movement
[48].
3.7.2 Visual 3D Motion Analysis System
After collecting the kinematic motion capture data using the Vicon Nexus System and
removing any false markers, the model was transferred to the C-Motion Visual 3D system for
processing and analysis. This system continues the use of the GCS and LCS right-handed
orthogonal systems with the most important direction being that of the bone segment assigned as
the Y-axis. This allows for the X-axis and Z-axis to be assigned based on the specific joint
associated with the segment. For example, the pelvis would have the Y-axis assigned direction
superiorly, X-axis assigned anteriorly, and the Z-axis would follow the right-hand rule pointing
laterally away from the body [48].
This system was then used to discern the various movements of each point throughout the
duration of a trial. The locations of these points were then compiled and analyzed to produce
joint angles. An advantage of this system, similar to that of the Vicon system, is that the
inclusion of the joint constraints minimizes soft tissue artifact and overall error during
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processing. Lastly, a disadvantage carries over from the Vicon system in that when a marker, or
point, is missing it creates a gap in data for that specific frame. Although it can be extrapolated,
this adds to the potential for error [48].
3.7.3 Markers and Marker Segments
Table 3: Marker Placement and Names (Torso, Pelvis, Arms, and Wrists)

Torso

Pelvis

Arms

Wrists

Clavicle
Sternum
Vertebrae Thoracicae 1
Vertebrae Thoracicae 10
Left Back
Left Anterior Superior Iliac Spine
Right Anterior Superior Iliac Spine
Left Posterior Superior Iliac Spine
Right Posterior Superior Iliac Spine
Right Shoulder Anterior
Right Shoulder Posterior
Left Shoulder Anterior
Left Shoulder Posterior
Right Elbow
Right Elbow Medial
Left Elbow
Left Elbow Medial
Right Wrist Anterior
Right Wrist Medial
Right Wrist Ulnar
Left Wrist Anterior
Left Wrist Medial
Left Wrist Ulnar
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CLAV
STRN
T1
T10
LBAK
LASI
RASI
LPSI
RPSI
RHOA
RSHOP
LSHOA
LSHOP
RELB
RELBM
LELB
LELBM
RWRA
RWRM
RWRU
LWRA
LWRM
LWRU

Table 4: Marker Placement Names (Hands and Fingers)

Hands
and
Fingers

Right Metacarpal Finger 1 (Thumb)
Right Metacarpophalangeal Joint Finger 1 (Thumb)
Right Metacarpal Finger 2 (Pointer)
Right Metacarpophalangeal Joint Finger 2 (Pointer)
Right Metacarpal Finger 3 (Middle)
Right Metacarpophalangeal Joint Finger 3 (Middle)
Right Metacarpal Finger 4 (Ring)
Right Metacarpophalangeal Joint Finger 4 (Ring)
Right Metacarpal Finger 5 (Pinky)
Right Metacarpophalangeal Joint Finger 5 (Pinky)
Left Metacarpal Finger 1 (Thumb)
Left Metacarpophalangeal Joint Finger 1 (Thumb)
Left Metacarpal Finger 2 (Pointer)
Left Metacarpophalangeal Joint Finger 2 (Pointer)
Left Metacarpal Finger 3 (Middle)
Left Metacarpophalangeal Joint Finger 3 (Middle)
Left Metacarpal Finger 4 (Ring)
Left Metacarpophalangeal Joint Finger 4 (Ring)
Left Metacarpal Finger 5 (Pinky)
Left Metacarpal Finger 5 (Pinky)
Right Proximal Phalangeal Finger 1 (Thumb)
Right Proximal Interphalangeal Joint Finger 1 (Thumb)
Right Proximal Phalangeal Finger 2 (Pointer)
Right Proximal Interphalangeal Joint Finger 2 (Pointer)
Right Proximal Phalangeal Finger 3 (Middle)
Right Proximal Interphalangeal Joint Finger 3 (Middle)
Right Proximal Phalangeal Finger 4 (Ring)
Right Proximal Interphalangeal Joint Finger 4 (Ring)
Right Proximal Phalangeal Finger 5 (Pinky)
Right Proximal Interphalangeal Joint Finger 5 (Pinky)
Left Proximal Phalangeal Finger 1 (Thumb)
Left Proximal Interphalangeal Joint Finger 1 (Thumb)
Left Proximal Phalangeal Finger 2 (Pointer)
Left Proximal Interphalangeal Joint Finger 2 (Pointer)
Left Proximal Phalangeal Finger 3 (Middle)
Left Proximal Interphalangeal Joint Finger 3 (Middle)
Left Proximal Phalangeal Finger 4 (Ring)
Left Proximal Interphalangeal Joint Finger 4 (Ring)
Left Proximal Phalangeal Finger 5 (Pinky)
Left Proximal Interphalangeal Joint Finger 5 (Pinky)
Right Middle Phalangeal Finger 1 (Thumb)
Right Proximal Interphalangeal Joint Finger 1 (Thumb)
Right Proximal Phalangeal Finger 2 (Pointer)

22

RM1
RMPP1
RM2
RMPP2
RM3
RMPP3
RM4
RMPP4
RM5
RMPP5
LM1
LMPP1
LM2
LMPP2
LM3
LMPP3
LM4
LMPP4
LM5
LMPP5
RPP1
RPDM1
RPP2
RPDM2
RPP3
RPDM3
RPP4
RPDM4
RPP5
RPDM5
LPP1
LPDM1
LPP2
LPDM2
LPP3
LPDM3
LPP4
LPDM4
LPP5
LPDM5
RMD1
RPDM1
RPP2

Table 4: Continued

Hands
and
Fingers
Cont.

Right Proximal Interphalangeal Joint Finger 2 (Pointer)
Right Proximal Phalangeal Finger 3 (Middle)
Right Proximal Interphalangeal Joint Finger 3 (Middle)
Right Proximal Phalangeal Finger 4 (Ring)
Right Proximal Interphalangeal Joint Finger 4 (Ring)
Right Proximal Phalangeal Finger 5 (Pinky)
Right Proximal Interphalangeal Joint Finger 5 (Pinky)
Right Distal Phalangeal Finger 1 (Thumb)
Right Distal Interphalangeal Joint Finger 2 (Pointer)
Right Distal Phalangeal Finger 2 (Pointer)
Right Distal Interphalangeal Joint Finger 3 (Middle)
Right Distal Phalangeal Finger 3 (Middle)
Right Distal Interphalangeal Joint Finger 4 (Ring)
Right Distal Phalangeal Finger 4 (Ring)
Right Distal Interphalangeal Joint Finger 5 (Pinky)
Right Distal Phalangeal Finger 5 (Pinky)
Left Middle Phalangeal Finger 1 (Thumb)
Left Distal Phalangeal Finger 1 (Thumb)
Left Distal Interphalangeal Joint Finger 2 (Pointer)
Left Distal Phalangeal Finger 2 (Pointer)
Left Distal Interphalangeal Joint Finger 3 (Middle)
Left Distal Phalangeal Finger 3 (Middle)
Left Distal Interphalangeal Joint Finger 4 (Ring)
Left Distal Phalangeal Finger 4 (Ring)
Left Distal Interphalangeal Joint Finger 5 (Pinky)
Left Distal Phalangeal Finger 5 (Pinky)

RPDM2
RPP3
RPDM3
RPP4
RPDM4
RPP5
RPDM5
RD1
RMD2
RD2
RMD3
RD3
RMD4
RD4
RMD5
RD5
LMD1
LD1
LMD2
LD2
LMD3
LD3
LMD4
LD4
LMD5
LD5

Table 5: Marker Segments
Pelvis
Torso
Right Upper Arm
Left Upper Arm
Right Lower Arm
Left Lower Arm
Right Metacarpal
Left Metacarpal
Right Proximal Phalangeal
Left Proximal Phalangeal
Right Middle-Distal Phalangeal
Left Middle-Distal Phalangeal

Pelvis
Torso
RUpper Arm
LUpper Arm
RLower Arm
LLower Arm
RMeta
LMeta
RPPhal
LPPhal
RMDPhal
LMDPhal
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Figure 2: Torso, Pelvis, Arms, and Wrist Markers

Figure 3: Torso, Pelvis, Arms, and Wrists Markers (Vicon)
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Figure 4: Torso, Pelvis, Arms, and Wrists Segments

Figure 5: Torso, Pelvis, Arms, and Wrists Segments (Vicon)
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Figure 6: Hand and Finger Markers
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Figure 7: Hand and Finger Segments
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Figure 8: Hand and Finger Markers and Segments (Vicon) Image 1

Figure 9: Hand and Finger Markers and Segments (Vicon) Image 2

3.8 Orthoses Being Tested
The thermal therapy orthoses that were tested are the IMAK Compression Arthritis
Gloves (Figure 10) [49] and Veturo Therapy Infrared Gloves (Figure 11) [50]. These gloves all
claim to decrease pain, increase range of motion, increase hand strength, increase hand dexterity,
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and increase hand function [51]. They are all currently the most popular thermal therapy gloves
used by patients with rheumatoid arthritis however, there is little to no evidence supporting
manufacturer claims [51].
These gloves decrease pain and swelling by increasing the temperature of the hands and
increasing blood oxygen levels [35]. They do not contain copper or any other known intervention
used to treat diseases such as RA.

Figure 10: IMAK Arthritis Gloves [49]

Figure 11: Veturo Therapy Infrared Gloves [50]
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3.9 Procedure
Each patient performed four trials correlating to each intervention; control, placebo
gloves, IMAK gloves, and Veturo gloves. The order of the trials was randomized using a
standard random number generator however, each trial procedure remained constant. After
appropriate consent forms were completed, the following procedure was followed for each trial.
•

Fit Glove Sizes

•

Warm-Up Period (20 minutes)
o Attach Markers During Warm-Up Period
o Calibrate the System

•

Range of Motion Exercises
o Fingers (Right and Left Hand Gathered Independently)
§

§

Metacarpophalangeal Flexion and Extension
•

Perform Once

•

Gather Temperature

•

Gather Pain

•

Repeat twice (3 exercises total)

Proximal Interphalangeal Flexion and Extension
•

Perform Once

•

Gather Temperature

•

Gather Pain

•

Repeat twice (3 exercises total)

o Thumb
§

Carpometacarpal Abduction and Adduction
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§

•

Perform Once

•

Gather Temperature

•

Gather Pain

•

Repeat twice (3 exercises total)

Metacarpophalangeal Flexion and Extension
•

Perform Once

•

Gather Temperature

•

Gather Pain

•

Repeat twice (3 exercises total)

•

Remove Markers

•

Arthritis Hand Function Test
o Grip Strength
§

Perform for Right Hand

§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

§

Repeat for Left Hand

o Pinch Strength (2-point)
§

Perform for Right Hand

§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

§

Repeat for Left Hand
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o Pinch Strength (3-point)
§

Perform for Right Hand

§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

§

Repeat for Left Hand

o Pegboard Dexterity
§

Perform for Right Hand

§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

§

Repeat for Left Hand

o Shoe Lacing
§

Gather Temperature for Both Hands

§

Gather Pain for Both Hands

§

Gather Blood Oxygen Level for Both Hands

o Button Board
§

Gather Temperature for Both Hands

§

Gather Pain for Both Hands

§

Gather Blood Oxygen Level for Both Hands

o Fasten Safety Pins
§

Gather Temperature for Both Hands

§

Gather Pain for Both Hands
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§

Gather Blood Oxygen Level for Both Hands

o Eating Utensil Dexterity
§

Gather Temperature for Both Hands

§

Gather Pain for Both Hands

§

Gather Blood Oxygen Level for Both Hands

o Pick Up Coins
§

Perform for Right Hand

§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

§

Repeat for Left Hand

o Lifting Weighted Tray
§

Gather Temperature for Both Hands

§

Gather Pain for Both Hands

§

Gather Blood Oxygen Level for Both Hands

o Pouring Water (Perform with Dominant Hand)
§

Gather Temperature

§

Gather Pain

§

Gather Blood Oxygen Level

•

Remove Gloves

•

Gather Temperature for Both Hands

•

Cool-Down Period (20 minutes)
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Throughout the study, all observations were recorded and the patient’s pain was
monitored. In order to adapt to the changing light, the system was recalibrated during every
warm-up period. This helped to prevent noise and to provide the best trial capture possible.
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CHAPTER 4: DATA ANALYSIS

4.1 Statistical Methods Used
Descriptive statistics were used to compare the differences between the means of the
three different interventions (placebo, IMAK Arthritis Gloves, and Veturo Therapy Infrared
Gloves) and the mean of the control. These statistics, such as mean and standard deviation, allow
for statistical and visual representations of the variations in the data results [52, 53]. Although a
power analysis was not done before this pilot study, it was completed after for the use of future
studies and can be found in later chapters.
4.2 Personal History Survey and Pain Catastrophizing Scale
4.2.1 Personal History Survey
The results of the personal history survey (Chapter 5.1.1) were used to gain insight into
the activities of daily ling affected by rheumatoid arthritis for each patient along with their
overall health and well-being. Descriptive statistics was performed on the ages of participants.
4.2.2 Pain Catastrophizing Scale
The scores of each patients’ Pain Catastrophizing Scale (Chapter 5.1.2) were summed
overall (questions 1-13) and then based on each subset; rumination (questions 8 – 11),
magnification (questions 6, 7, 13), and helplessness (questions 1-5, 12). These scores were then
converted into percentiles using the PCS Manual and evaluated based on the percentile (i.e.
someone scoring in the 75th percentile overall catastrophizes their pain more than 75% of the
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population) [3]. The mean and standard deviation of the overall summation, rumination
summation, magnification summation, and helplessness summations were calculated in addition
to the conversion to percentiles using the PCS Manual.
4.3 Arthritis Hand Function Test
The tasks within the Arthritis Hand Function Test were measured using an adapted
sphygmomanometer (mm Hg), pinch meter (kg), stopwatch (seconds), weight (ounces in the
form of number of soup cans), and volume (quarts). The average scores within each task were
analyzed based on the AHFT worksheets and categorized (severe impairment, moderate
impairment, mild impairment, and effective) appropriately. In addition, descriptive statistics of
the measurements were analyzed to further compare the four groups.
4.4 Range of Motion
The range of motion tasks were recorded using the Vicon Nexus Motion Capture System.
This data was then transferred to the C-Motion Visual 3D Motion Analysis Software where the
joint angles were calculated based on the position of certain markers relative to others in each
frame. The maximum joint angles reached were identified and compared to known maximum
angles for the same range of motion exercises. The mean and standard deviation of the maximum
joint angles was also calculated in order to provide added information when comparing the
orthoses to the placebo glove and the control group (Table 6).
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Table 6: Range of Motion Descriptive Statistics (Angular Degrees)
Right Hand
Left Hand
Control Placebo IMAK Veturo Control Placebo IMAK Veturo
85.5
84.9
84.7
85.7
86.5
85.8
86.6
86.8

Mean
Meta. Standard
1
0.9
1.3
0.8
Deviation
Mean
92.9
92
90.7
92
2
Prox.
Standard
1.9
1.8
4.1
2.1
Deviation
Mean
52
51
51.2
52.1
Carp.3 Standard
1.6
1.5
1.9
1.7
Deviation
Mean
76.7
75.9
76.5
77
4
Meta. Standard
1.3
1
1
0.9
Deviation
1
Finger Metacarpophalangeal Flexion and Extension
2
Finger Proximal Interphalangeal Flexion and Extension
3
Thumb Carpometacarpal Abduction and Adduction
4
Thumb Metacarpophalangeal Flexion and Extension
1

1

0.9

0.9

0.8

94.4

93.3

93.6

94.6

1.1

0.9

1

1

55.4

54.6

54.9

55.7

1.5

1.2

1.7

1.9

77.1

76.1

76.7

77.2

1.5

1.1

1.1

1.1

4.5 Rheumatoid Arthritis Pain Scale
The self-reported scores of the RAPS were recorded after the completion of each task
within the AHFT and each range of motion exercise. The average scores of each task or
movement were analyzed using descriptive statistics in order to further compare the four groups;
control, placebo, IMAK, and Veturo.
4.6 Additional Outcome Measures
Temperature was recorded using a laser thermometer (°F) and the blood oxygen level
was recorded using a pulse oximeter (%). The palm temperature was recorded after each task
within the AHFT and each exercise of the ranges of motion. The blood oxygen level was
recorded after each task within the AHFT only. The mean and standard deviation of the recorded
palm temperatures and blood oxygen levels were calculated to compare the differences between
the four groups tested.
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CHAPTER 5: RESULTS
5.1 Personal History and Pain Catastrophizing Scale
5.1.1 Personal History Survey
Patients were first given a personal history survey which included an adaptation of the
Health Assessment Questionnaire (HAQ) developed and validated by Stanford University [2].
The tabulated results can be seen in Table 7 below.
Table 7: Personal History Survey Patient Demographics
Gender
Age
Year of
Diagnosis

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

F
56

F
60

F
68

F
69

F
36

2017

2013

2015

2002

2017

Medications

Methotrexate,
Folic Acid,
Hydroxychloroq
uine

Enbrel,
Methotrexate

Methotrexate,
Rituxan

Orthosis

Wrist Brace

None

None

Methotrexate,
Plaquenil,
Vitamin D,
Turmeric, Folic
Acid
None

3.5

3

4

4

3

5

10

6

8

9

2

1

1

2

2

Began With

Idiopathic

Tick Bite

Muscle Disease

Car Accident

Affects

Fingers, Hands,
Wrists, Neck,
Back, Toes

Fingers, Hands,
Elbows,
Shoulders,
Toes, Feet,
Ankles

Fingers, Feet,
Ankles, Knees

Car Accident
Fingers, Hands,
Wrists,
Shoulders,
Neck, Toes,
Feet, Ankles,
Knees

010

Normal
Daily
Pain
Most
Severe
Pain
Least
Severe
Pain
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Plaquenil,
Diclofenac
None

Fingers, Hands,
Wrists, Toes,
Feet, Ankles,
Knees, Hips

Table 7: Continued
Blood Tests

Negative Rf,
Anti-CCP,
HLA-DR4

Positive Rf
factor, AntiCCP

NA

Positive Rf
Factor

Positive Rf factor,
Anti-CCP

Diagnosed
By

MD*

MD*

MD*

MD*

MD*

2

0

0

0

0

0

0

0

2

0

0

2

4

4

0

0

2

2

2

0

4

0

0

4

2

2

0

2

0

2

4

0

2

2

0

0

0

0

0

2

0

0

4

2

2

0

0

4

2

2

0

0

2

4

2

Aids for
Dressing

None

None

None

Cane

None

None

None

Arising

None

0
6

Dress
Yourself
Shampoo
Hair
Stand Up
from A
Chair
Get In and
Out of Bed
Cut Your
Meat
Lift A Full
Glass to
Your
Mouth
Open A
New Milk
Carton
Walk
Outdoors
on Flat
Ground
Climb 5
Steps
Go Down
5 Steps
Walk on
Uneven
Ground

Assistive
Technology
Used
Need Help
to Complete
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Table 7: Continued

0
6

Wash and
Dry Your
Body
Take a Tub
Bath
Get On/Off
the Toilet
Reach Up
to Get a
5lb Bag
Bend
Down to
Pick Up
Clothes
Open Car
Doors
Open
Previously
Opened
Jars
Turn
Faucets
On/Off
Run
Errands
Get In/Out
of Car
Do Chores
Dance
Swim

Assistive
Technology
Need Help
to Complete
Overall
Health
Morning
Stiffness
Length of
Stiffness
Pain the
Week Prior
to Testing
(0-100)

2

0

0

0

0

0

0

6

6

4

0

0

4

4

2

4

2

2

4

4

0

0

2

2

2

2

0

0

0

0

4

2

0

2

6

0

0

0

4

0

2

0

2

0

2

0

0

2

0

2

6
0
0

2
0
0

2
4
2

6
2
2

6
0
2
Bathtub Seat, Jar
opener

Jar Opener

Raised Toilet
Seat

Bathtub Bar

Raised toilet
seat, bathtub
bar, handled
appliances for
reach

Grip

None

None

Reach

Grip activities

Very Good

Very Good

Fair

Very Good

Very Good

Yes

Yes

Yes

Yes

Yes

15 minutes

30 minutes

15 minutes

3 minutes

2 hours

70

25

40

30

45

40

Table 7: Continued
Morning
Ache
Length of
Ache
Take
Anything for
Ache/Pain
If Yes, What
Fever

Yes

Yes

Yes

Yes

Yes

20 minutes

All Day

15 minutes

30 minutes

2 hours

Yes

Yes

Yes

No

Yes

Tylenol

Advil

Tramadol

NA

Diclofenac

Dizziness
Tiredness
Blurred
Vision
Ringing in
Ears
Hearing
Difficulties
Mouth Sores
Dry Mouth
Loss/Change
in Taste
Headache

This week
Today, this
week, this
month
Today, this
week, this
month

Joint
Swelling
Leg/Ankle
Swelling
Low Back
Pain
Muscle Pain
Neck Pain

This week

This week

This week, this
month

Today

This week, this
month
This month

This month
Today

This month

Chest Pain
Shortness of
Breath
Wheezing
Joint Pain

This week, this
month
Today, this week,
this month

This month

Today, this
week, this
month
Today, this
week, this
month

This week, this
month

This week

This month

This month

This week, this
month

Today

Today, this
week, this
month

This month

Today, this week,
this month

This week

This week

This month

Today, this week,
this month
This week, this
month

Today, this
week, this
month
Today, this
week, this
month
Today, this
week, this
month

This week, this
month
Today, this
week, this
month

This month
This month

This month
This month
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Table 7: Continued
Today, this
week, this
month

Weakness of
Muscles
Loss of
Appetite

This week, this
month

This week, this
month

Nausea
Heartburn

Today, this
week, this
month

Today, this
week, this
month

This month

This week, this
month

Indigestion
Pain in
Stomach
Area
Liver
Problems
Lower
Abdomen
Pain
Diarrhea
Constipation
Black/Tarry
Stool
Vomiting
Sadness
Depression
Insomnia
Nervousness
Trouble
Thinking
Easy
Bruising
Hives/Welts
Itching
Rash
Pregnancy
Breakfast
Snack Before
Lunch
Lunch
Snack Before
Dinner

This week, this
month

This week, this
month

Today, this
week, this
month

This month

This month
This month
This month
This month

This month

This month

This week
This week
This week
This week
Today, this
week, this
month

Today, this
week, this
month

No
Light

No
Light

No
Light

This month
No
Light

No

No

Yes

Yes

No

Light

Light

Light

Light

Light

Yes

No

No

Yes

Yes
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No
Hearty

Table 7: Continued
Dinner
Snack Before
Bed

Hearty

Hearty

Light

Light

Light

Yes

Yes

Yes

Yes

Yes

Vegetables

Conventional

Conventional

Conventional

Conventional

Fruits

Conventional

Conventional

Conventional

Organic

Protein

Conventional

Organic

Conventional

Conventional

Raw Nuts
Almonds
Roasted Nuts
Fats
Olive Oil
Butter
Salt
Oil
Fried Food
Changing
Glasses of
Water Per
Day
Type of
Water
Exercise
Frequency
Exercises

Yes

Conventional,
Organic
Conventional,
Organic
Conventional,
Organic

Yes
Yes

Yes
Yes

Yes
Conventional
Sea, Table
Vegetable

Yes
Conventional
Sea

Conventional

Yes
Conventional
Table
Vegetable

Yes

Table
Fish
Yes

None

None

Eating Habits

None

3

8

4

4

12

Bottled

Bottled, Filtered

Bottled

Bottled

Tap, Filtered

Monthly

Weekly

None

Daily

Weekly

Gardening,
Stationary Bike

Water exercises

None

Walk

Yoga,
Gardening,
Weights

Begin
exercising

*MD = Rheumatologist
As seen in Table 7 above, all subjects were female and had their rheumatoid arthritis
diagnosed by a Rheumatologist. The average age of all participants was 57.8 years ± 13.3 years
with individual ages ranging from 36 to 69. Four participants self-diagnosed the event that
caused their RA symptoms to begin. The most frequent self-reported cause was a car accident (2)
with the other two stemming from a muscular disease and a tick bite. One patient related that
their RA was idiopathic. Additionally, all subjects were right hand dominant.
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Within the personal history survey, participants indicated that in spite of the numerous
activities of daily living affected by their RA (63 out of 120), four of the five patients selfreported that they were in “very good” health and that their RA affects them, on average, 53% of
the time. Patients also self-reported that they were affected by other health factors, such as
heartburn and mouth sores, 32% of the time.
5.1.2 Pain Catastrophizing Scale
This scale was used to determine the psychological mindset of each patient with regards
to pain, specifically the pain they experience related to their rheumatoid arthritis. The summary
of each patient and the average responses of all patients can be seen below in Figure 12. The
scale has a minimum rating of 0 and a maximum rating of 4.

Pain Catastrophizing Scale Scores
Self-Reported Score (Max 4)

3.5
3

3

2.5
2

2

2

2

2

2

2

2

1

1

2

1.5
1

Patient 1
Patient 2
Patient 3

1

1

1

1

1

1

1

1

1

Patient 4
Patient 5

0.5
0
1

0
2

0
3

0
4

0
5

0 0 0
6 7 8
Question

0
9

0
10

0
11

0
12

0
13

Figure 12: Pain Catastrophizing Scale Results
As seen in the above Figure 12, the highest patient reported score was a 3 to question 1.
This statement, “I worry all the time about whether the pain will end”, was assigned a 3
correlating to the patient agreeing “to a great degree” [3]. The highest average score also
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correlated to question 1 but was a 1.8. This score is between 1, “to a slight degree”, and 2, “to a
moderate degree” [3]. The mode score was 0, answered 30 times by all 5 patients, accounting for
46% of the self-reported answers. The spread of the self-reported scores can be seen below, in
Table 7 and Figure 13.
Table 8: Frequency of Self-Reported Scores to the PCS
Self-Reported Score
0 – “not at all”
1 – “to a slight degree”
2 – “to a moderate degree”
3 – “to a great degree”
4 – “all the time”

Frequency
30
22
12
1
0

PCS Score Frequency
30

22

12

0

1

2

1

0

3

4

Figure 13: Frequency of Self-Reported Scores to the PCS
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Overall PCS Scores of Patients
25

Total Scores (Max 52)

20

20
Patient 1
Patient 2

15

Patient 3

12
10

10
8

8

Patient 4
Patient 5
Average

5
1
0

Figure 14: Overall PCS Scores of Patients
In the above Figure 14 Overall PCS Scores of Patients it can be seen that the highest
cumulative score was 20, this equates to the 50th percentile of patients (Table 5.4 PCS Score
Percentiles) meaning that this patient is in the 50th percentile of people with respect to
catastrophizing their pain. On the other hand, the lowest overall score was 1, which falls under
the 4th percentile of pain catastrophizing. This is interpreted such that the highest scoring patient
catastrophizes their pain more than 50% of people who experience pain on a daily basis while the
lowest scoring patient catastrophizes their pain more than only 4% of people.
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PCS Subscales of Patients
12

11

Categorical Scores

10
8
6
4

Rumination
5

5

5

4

4 4 4

4
3 3

2

2

2
1

Magnification
Helplessness

2

1
0 0

0
1

2

3

4

5

AVERAGE

Figure 15: PCS Subscale Scores of Patients

The PCS is divided into three subscales; rumination, magnification, and helplessness [3].
These subscales are meant to allow interpreters to pinpoint the most hindering mentality and to
use identify areas of influence. Magnification was determined to be the leading cause of pain
catastrophizing within these participants, with the average subscale score corresponding to the
50th percentile, while the average rumination fell into the 19th percentile and helplessness fell into
the 36th. The highest subscale score of an 11 in the helplessness category is ranked in the 64th
percentile, while the lowest of 0 in both the rumination and magnification subsets ranked in the
3rd and 14th percentiles respectively. The associated percentiles of the overall scores and the
subsets can be seen in Table 9.
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Table 9: PCS Score Percentiles
Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Average

50th

19th

4th

31st

19th

24th

31st

13th

3rd

26th

13th

19th

63rd

27th

14th

63rd

63rd

50th

64th

36th

10th

29th

16th

36th

Overall
Percentile
Rumination
Percentile
Magnification
Percentile
Helplessness
Percentile

Given that the highest overall score was in the 50th percentile and the second lowest was
in the 31st [3], it is suggested that patients who participated in the study may not be
psychologically handicapped by their pain. This was also supported with the average overall
score of 10 ± 7. It also implies that the self-reported pain scores of the Arthritis Hand Function
Test and range of motion tasks may not be severely clouded by the psychological aspect of pain.
5.2 Arthritis Hand Function Test
5.2.1 Grip Strength
The grip strength was measured using an adapted sphygmomanometer where the patient
is instructed to grasp the cuff, beginning at 20mm Hg, and squeeze as strongly as possible, first
with their right hand and then with their left. This test was performed once during each trial.
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Figure 16: Grip Strength Image
As seen in the below Figure 18 and Table 10, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All
patients were categorized as severely impaired (score of 100 mm Hg or less) when performing
the task with the IMAK. Subjects were collectively categorized as having moderate impairment
(100 mm Hg – 150 mm Hg) with the control, placebo, and Veturo gloves. Within the left hand,
the Veturo gloves scored slightly higher within the moderate impairment category. This was the
only instance where a glove scored higher than the control during the grip strength test. Based on
these results, the data implies that there may be severe to moderate impairment when using the
gloves and that there is likely no advantage to performing grip strength tasks with the gloves.
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Grip Strength
160
140
Force (mm Hg)

120

104

100

106

101

100

104

108
96

Control

84

80

Placebo

60

IMAK
Veturo

40
20
0

Right Hand

Left Hand

Figure 17: Average Grip Strength for All Subjects (mm Hg)
Table 10: Hand Function Profile - Grip Strength (mm Hg)

Right Hand
Left Hand

Severe
Impairment
I
I

Moderate
Impairment
C, P, V
C, P, V

Mild Impairment

100
150
C= Control, P = Placebo, I = IMAK, V= Veturo

Effective

200

5.2.2 2-Point Pinch Strength
The 2-point pinch strength was measured using a pinch meter where the patient was
instructed to use their index finger and thumb to squeeze as strongly as they could, first with
their right hand and then with their left. This test was performed once during each trial.
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Figure 18: 2-Point Pinch Strength Images
As seen in the below Figure 21 and Table 11, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. During
the right hand portion, the IMAK and Veturo gloves were classified as causing mild impairment
(2.5 kg – 5 kg) while the control and placebo glove were categorized as being effective (5kg or
higher). This was not the case for the left hand portion, where all four groups were classified as
being effective (5 kg or higher). Based on these results, the data suggests that the use of orthoses
in the non-dominant hand may be beneficial when performing the 2-point pinch strength task.
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2 Point Pinch Strength
12
10

Force (kg)

8
6

7
5

5

5
4

4

Control
5

5

Placebo
IMAK

4

Veturo

2
0

Right Hand

Left Hand

Figure 19: Average 2-Point Pinch Strength for All Subjects (kg)
Table 11: Hand Function Profile - 2-Point Pinch Strength (kg)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

I, V

C, P
C, P, I, V

Right Hand
Left Hand
1.0
2.5
C= Control, P = Placebo, I = IMAK, V= Veturo

5.0

5.2.3 3-Point Pinch Strength
The 3-point pinch strength was measured using a pinch meter where the patient was
instructed to use their index finger, middle finger and thumb to squeeze as strongly as possible,
first with their right hand and then with their left. This test was performed once during each trial.
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Figure 20: 3-Point Pinch Strength Images
As seen in the below Figure 21 and Table 12, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The
right hand showed that all but the IMAK gloves were considered to be effective (5 kg or higher).
While the left hand produced results that were all categorized as being effective or causing no
impairment (5kg or higher). This information implies that the IMAK orthoses may cause a mild
impairment when used on the dominant hand but could be effective when used on the nondominant hand.
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3 Point Pinch Strength
9
8
7
Force (kg)

6
5

6
5

5

5

5

5

5

Placebo

4

4

Control
IMAK

3

Veturo

2
1
0

Right Hand

Left Hand

Figure 21: Average 3-Point Pinch Strength for All Subjects (kg)
Table 12: Hand Function Profile - 3-Point Pinch Strength (kg)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

I

C, P, V
C, P, I, V

Right Hand
Left Hand
2.0
3.5
C= Control, P = Placebo, I = IMAK, V= Veturo

5.0

5.2.4 Pegboard Dexterity
Pegboard dexterity was tested using a 9-hole pegboard where the patient was instructed
to input all pegs into holes on the pegboard and then remove them as quickly as possible. Each
patient was specifically instructed to use their index finger and thumb to pick up individual pegs
off the table and place them in a hole, and when finished, remove all pegs as quickly as they can.
Patients performed this test first with their right hand and then with their left. This test was
performed once during each trial.
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Figure 22: Pegboard Dexterity Images
As seen in the below Figure 23 and Table 13, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. Both the
right and left hand showed that the control and placebo were effective (22 seconds or less) and
did not impair the user’s ability to perform the pegboard test. However, the IMAK and Veturo
orthoses were classified as mildly impairing (22 seconds – 25 seconds) the user and their ability
to complete the task as quickly as they can. Based on this data, it can therefore be suggested that
there may be a slightly mild impairment when using the orthoses to complete the pegboard
dexterity test.
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Pegboard Dexterity
35
30

Seconds

25
20

20

21

23

24

23

21

23

21

Control
Placebo

15

IMAK

10

Veturo

5
0

Right Hand

Left Hand

Figure 23: Average Pegboard Dexterity Time for All Subjects (Seconds)
Table 13: Hand Function Profile - Pegboard Dexterity (Seconds)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

I, V
I, V

C, P
C, P

Right Hand
Left Hand
28
25
C= Control, P = Placebo, I = IMAK, V= Veturo

22

5.2.5 Shoe Lacing
Shoe lacing was tested using a single shoe and shoelace where the patient was instructed
to lace the shoe as quickly as possible. This test is bimanual and was performed once during each
trial.
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Figure 24: Shoe Lacing Images
As seen in the below Figure 25 and Table 14, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The
control was classified as causing mild impairment (32 seconds – 38 seconds), whereas the
placebo was categorized as causing moderate impairment (38 seconds – 44 seconds) to the user.
The IMAK and Veturo gloves fell under the causing severe impairment category (44 seconds and
higher). This data suggests that the use of orthoses could cause a disadvantage when used to lace
a shoe.
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Shoe Lacing
80
70
60
50

Seconds

50

Control

45

42

Placebo

37

40

IMAK

30

Veturo

20
10
0

Figure 25: Average Shoe Lacing Time for All Subjects (Seconds)
Table 14: Hand Function Profile - Shoe Lacing (Seconds)
Severe
Impairment
V, I

Moderate
Impairment
P

Mild Impairment

Effective

C

44
38
C= Control, P = Placebo, I = IMAK, V= Veturo

32

5.2.6 Button Board
The button board test was performed using a traditional therapy button board where the
patient was instructed to button and unbutton the entire board (4 buttons) as quickly as possible.
This test is bimanual and was performed once during each trial.
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Figure 26: Button Board Images
As seen in the below Figure 27 and Table 15, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. Both the
control and placebo were categorized as effective (23 seconds or less) while the IMAK and
Veturo orthoses were classified as causing mild impairment (23 seconds – 35 seconds) to the
user. Both the IMAK and Veturo scores were very close to the 23-second cutoff; the average
being 24 seconds for each glove. Therefore, the data alludes to a possibility that the IMAK and
Veturo orthoses may cause a slight mild impairment that may or may not be seen when
compared to performing the button board task without the aid of an orthosis.
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Figure 27: Average Button Board Time for All Subjects (Seconds)
Table 15: Hand Function Profile - Button Board (Seconds)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

I, V

C, P

47
35
C= Control, P = Placebo, I = IMAK, V= Veturo

23

5.2.7 Safety Pin Fastening
The safety pin fastening test was performed using two safety pins and a piece of folded
cloth where the subject was instructed to fasten both safety pins into the cloth as quickly as
possible. This test is bimanual and was performed once during each trial.
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Figure 28: Safety Pin Fastening Images
As seen in the below Figure 29 and Table 16, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The
control and IMAK gloves were categorized as causing mild impairment (15 seconds – 19
seconds) while the placebo was classified as causing moderate impairment (19 seconds – 23
seconds) and the Veturo orthoses were classified as causing severe impairment (23 seconds or
higher). Therefore, the data suggests that the IMAK orthoses may cause the same amount of
impairment as if the user was not using an orthosis.
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Figure 29: Average Safety Pin Fastening Time for All Subjects (Seconds)
Table 16: Hand Function Profile - Safety Pin Fastening (Seconds)
Severe
Impairment
V

Moderate
Impairment
P

Mild Impairment

Effective

C, I

23
19
C= Control, P = Placebo, I = IMAK, V= Veturo

15

5.2.8 Cutting Putty
The cutting putty test was performed using therapeutic putty and eating utensils. The
subject was instructed to cut along two lines down to the plate as quickly as possible. This test is
bimanual and was performed once during each trial.

62

Figure 30: Cutting Putty Images
As seen in the below Figure 31 and Table 17, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All four
trials were considered to be severely impaired (28 seconds or higher) with the scores of the
orthoses being much higher than those of the control and placebo. Therefore, the data suggests
that although the control is classified as severely impaired (28 seconds or higher), the use of the
orthoses may not aid the user when cutting putty.
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Figure 31: Average Cutting Putty Time for All Subjects (Seconds)
Table 17: Hand Function Profile - Cutting Putty (Seconds)
Severe
Impairment
C, P, I, V

Moderate
Impairment

Mild Impairment

28
23
C= Control, P = Placebo, I = IMAK, V= Veturo

Effective
18

5.2.9 Picking Up Coins
The coin pickup test was performed using four coins (1 penny, 1 nickel, 1 dime, and 1
quarter) and a change box. The subject was instructed to pick up one coin at a time and place it
into the slotted change box as quickly as possible, first with their right hand and then with their
left. This test was performed once during each trial.
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Figure 32: Coin Pickup Images
As seen in the below Figure 33 and Table 18, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All trials
were categorized as effective (11 seconds or less) with the Veturo gloves scoring slightly better
than the other groups in the right hand. Although the orthoses were classified as effective (11
seconds or less) for the left hand, they were shown to be slightly higher than the control.
Therefore, the data suggests that the use of the Veturo gloves in the dominant hand may be
beneficial to the user while the use of either orthoses in the non-dominant hand may not provide
any assistance when picking up coins.
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Figure 33: Average Coin Pickup Time for All Subjects (Seconds)
Table 18: Hand Function Profile - Coin Pickup (Seconds)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

Right Hand
Left Hand

C, P, I, V
C, P, I, V
15
13
C= Control, P = Placebo, I = IMAK, V= Veturo

11

5.2.10 Lifting Cans
The lifting cans test was performed using 12 soup cans (10.5oz each) and a tray. The
weighted tray was placed on a table in front of the subject who was then instructed to lift the
weighted tray straight up while remaining seated. The max weight was determined by placing
one additional can at a time onto the tray and asking the patient if they felt like they could lift
more after performing the motion. This test is bimanual and was performed once during each
trial.
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Figure 34: Lifting Cans Images
As seen in the below Figure 35 and Table 19, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. The
control was classified as causing mild impairment (less than 12 cans but more than 9) while the
placebo, IMAK and Veturo orthoses were categorized as effective (12 cans). Therefore, the data
suggests that using orthoses while lifting a weighted tray may provide some additional aid.
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Figure 35: Average Lifting Cans Test for All Subjects (Number of Cans)
Table 19: Hand Function Profile - Lifting Cans (Number of Cans)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective

C

P, I, V

6
9
C= Control, P = Placebo, I = IMAK, V= Veturo

12

5.2.11 Pouring Water
The pouring water test was performed using a 2-quart pitcher and a cup. The subject was
instructed to lift the pitcher off the table with their dominant hand and pour water into the cup. If
they were unable to do so water would be taken out of the pitcher until the subject could lift it.
This test is bimanual and was performed once during each trial.
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Figure 36: Pouring Water Images
As seen in the below Figure 37 and Table 20, the average scores of all subjects were
calculated and scored based on the Arthritis Hand Function Test Hand Function Profile. All trials
were classified as effective (2 quarts) as no subjects were unable to lift the full 2-quart pitcher.
As there was no difference in the scores, the data suggests that there is no advantage or
disadvantage to using orthoses when performing the pouring water test.
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Figure 37: Average Pouring Water Test for All Subjects (Quarts)
Table 20: Hand Function Profile - Pouring Water (Quarts)
Severe
Impairment

Moderate
Impairment

Mild Impairment

Effective
C, P, I, V

1
1.5
C= Control, P = Placebo, I = IMAK, V= Veturo

2

5.3 Range of Motion
The following range of motion exercises were performed using the control, placebo,
IMAK, and Veturo orthoses. The maximum joint angles of each movement were compared for
statistical significance.
5.3.1 Finger Metacarpophalangeal Flexion and Extension
Finger Metacarpophalangeal flexion and extension was performed 3 times with each
group for a total of 12 flexion/extensions per participant. Subjects were given a picture
representation (Appendix C) of the movement along with a demonstration and then asked to
perform to the best of their abilities.
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Figure 38: Metacarpophalangeal Flexion and Extension Images

Figure 39: Finger Metacarpophalangeal Flexion and Extension (Vicon) Images
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Figure 40: Average Finger Metacarpophalangeal Flexion and Extension (Right Hand)
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Figure 41: Average Finger Metacarpophalangeal Flexion and Extension (Left Hand)
As seen in the above Figures 40 and 41, the average joint angles for the finger
metacarpophalangeal flexion and extension of the right and left hand are shown. Within each
hand, there was no little difference between the maximum joint angles reached between
intervention groups and the control. Therefore, the data suggests that the use of the orthoses may
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not increase or decrease the maximum joint angle when performing metacarpophalangeal flexion
and extension.
5.3.2 Finger Proximal Interphalangeal Flexion and Extension
Finger Proximal Interphalangeal flexion and extension was performed 3 times with each
group for a total of 12 flexion/extensions per participant. Subjects were given a picture
representation (Appendix C) of the movement along with a demonstration and then asked to
perform to the best of their abilities.

Figure 42: Finger Proximal Interphalangeal Flexion and Extension Images
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Figure 43: Finger Proximal Interphalangeal Flexion and Extension (Vicon) Images
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Figure 44: Average Finger Proximal Interphalangeal Flexion and Extension (Right Hand)
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Figure 45: Finger Proximal Interphalangeal Flexion and Extension (Left Hand)
As seen in the above Figures 44 and 45, the average joint angles for the finger proximal
interphalangeal flexion and extension of the right and left hand are shown. Within each hand,
little to no difference between the maximum joint angles reached between intervention groups
and the control were seen. Therefore, this data implies that the use of the orthoses may not
increase or decrease the maximum joint angle when performing proximal interphalangeal flexion
and extension.
5.3.3 Thumb Carpometacarpal Abduction and Adduction
Thumb Carpometacarpal abduction and adduction was performed 3 times with each
group for a total of 12 abduction/adductions per participant. Subjects were given a picture
representation (Appendix C) of the movement along with a demonstration and then asked to
perform to the best of their abilities.
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Figure 46: Thumb Carpometacarpal Abduction and Adduction Images

Figure 47: Thumb Carpometacarpal Abduction and Adduction (Vicon) Images
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Figure 48: Average Thumb Carpometacarpal Abduction and Adduction (Right Hand)
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Figure 49: Average Thumb Carpometacarpal Abduction and Adduction (Left Hand)
As seen in the above Figures 48 and 49, the average joint angles for the thumb
carpometacarpal abduction and adduction of the right and left hand are shown. Within each hand,
there was no little to no difference between the maximum joint angles reached between
intervention groups and the control. This data therefore implies that the use of the orthoses may
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not increase or decrease the maximum joint angle when performing thumb carpometacarpal
abduction and adduction.
5.3.4 Thumb Metacarpophalangeal Flexion and Extension
Thumb Metacarpophalangeal flexion and extension was performed 3 times with each
group for a total of 12 flexion/extensions per participant. Subjects were given a picture
representation (Appendix C) of the movement along with a demonstration and then asked to
perform to the best of their abilities.

Figure 50: Thumb Metacarpophalangeal Flexion and Extension Images

Figure 51: Thumb Metacarpophalangeal Flexion and Extension (Vicon) Images
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Figure 52: Average Thumb Metacarpophalangeal Flexion and Extension (Right Hand)
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Figure 53: Average Thumb Metacarpophalangeal Flexion and Extension (Left Hand)
As seen in the above Figures 52 and 53, the average joint angles for the thumb
metacarpophalangeal flexion and extension of the right and left hand are shown. Within each
hand, there was little to no difference between the maximum joint angles reached between
intervention groups and the control. Therefore, this information implies that the use of the
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orthoses may not increase or decrease the maximum joint angle when performing thumb
metacarpophalangeal flexion and extension.
5.4 Rheumatoid Arthritis Pain Scale
5.4.1 Arthritis Hand Function Test
After each task was completed, subjects were asked to rate the pain they experienced
while performing the task using the Rheumatoid Arthritis Pain Scale [10]. The following figures
and results are the findings of the pain associated with each task of the Arthritis Hand Function
Test.
5.4.1.1 Grip Strength Pain
As seen in the below Figure 54, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. On average, the
dominant, right, hand experienced more pain (3 ±2) than the non-dominant, left, hand (2 ±2). As
seen in the right hand, the difference between the pain experienced when performing the grip
strength task with the control versus the IMAK was 2 while the difference between the control
and Veturo was 1. Alternately, the IMAK performed worse than the control in the left hand
(difference of 1) while the Veturo performed as well as the control and placebo. This data
suggests that there might be an advantage to using the IMAK or Veturo in the dominant hand
while there might not be an advantage in the non-dominant hand.
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Figure 54: Average Pain for Grip Strength
5.4.1.2 2-Point Pinch Strength Pain
As seen in the below Figure 55, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The control,
IMAK and Veturo gloves all scored on average a 2 (±1) in the right hand while the placebo
averaged 3 (±2). The orthoses remained the same (2 ±1) in the left hand while the averages of the
control and placebo both decreased. This data implies that the use of the IMAK or Veturo
orthoses may not provide an advantage when performing the 2-point pinch strength test.
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Figure 55: Average Pain for 2-Point Pinch Strength
5.4.1.3 3-Point Pinch Strength Pain
As seen in the below Figure 56, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. As seen in the
below figure, there was much more variability in the self-reported pain felt in the dominant hand
when compared to the non-dominant hand; a difference of the lowest score to the highest score
being 2 for the dominant (right) hand and 0 for the non-dominant (left) hand. When comparing
within the right hand, the control was reported to cause the least amount of pain (1 ±1), the
placebo the most amount (3 ±1), and the orthoses were both reported to cause on average a pain
level of 2 ±1. This data suggests that the use of the IMAK or Veturo orthoses may not provide an
advantage when used during the 3-point pinch strength with respect to pain.
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Figure 56: Average Pain for 3-Point Pinch Strength
5.4.1.4 Pegboard Dexterity Pain
As seen in the below Figure 57, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The right and left
hands were similar in that three of the four groups had an average reported score of 1 ±1 with
one group averaging 2 ±1. For the right hand this single group was the placebo whereas the
higher score of the left hand was the IMAK glove. This data suggests that the use of either
orthosis on the dominant hand may not provide any advantage towards pain but the use of the
IMAK on the non-dominant hand may cause a disadvantage.
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Figure 57: Average Pain for Pegboard Dexterity
5.4.1.5 Shoe Lacing Pain
As seen in the below Figure 58, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The shoe-lacing
task was verbally reported to be one of the more difficult tasks by multiple subjects however, the
pain scores remain relatively low. The placebo and IMAK both had, on average, higher selfreported scores (2 ±2) than the control and Veturo (1 ±1). This data suggests that the use of the
IMAK gloves may increase the pain reported by users while the Veturo gloves may not provide
any advantage for pain when performing the shoe lacing test.
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Figure 58: Average Pain for Shoe Lacing
5.4.1.6 Button Board Pain
As seen in the below Figure 59, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The button board
task was one of the least challenging tasks for subjects with respect to pain, keeping the selfreported scores relatively low. The control and IMAK groups were found to be the highest with
respect to pain (2 ±2 and 2 ±1 respectively) while the placebo and Veturo gloves were the lowest
scoring (1 ±1). This information implies that the use of the Veturo gloves may decrease the pain
experienced when performing the button board portion of the AHFT.
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Figure 59: Average Pain for Button Board
5.4.1.7 Safety Pin Fastening Pain
As seen in the below Figure 60, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The average
scores were the same for all groups (2) with slight variations in the standard deviation (control
and placebo: ±1, IMAK and Veturo: ±2). This data suggests that the use of either orthoses may
not help or hurt the overall pain experienced during the safety pin fastening test.
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Figure 60: Average Pain for Fastening Safety Pins
5.4.1.8 Cutting Putty Pain
As seen in the below Figure 61, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The cutting putty
task was arguably the most difficult for subjects with respect to pain, both through their selfreported scores and verbal feedback when completing the task. The Veturo gloves scored the
lowest self-reported pain scores out of all of the groups with an average of 3 (±3). This
information implies that the use of the Veturo gloves when performing the cutting putty test may
reduce the self-reported pain experienced by users.
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Figure 61: Average Pain for Cutting Putty
5.4.1.9 Picking Up Coins Pain
As seen in the below Figure 62, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The right hand
showed slight variability amongst groups with the IMAK gloves averaging 2 (±1) and the other
groups averaging 1 (±1) whereas the left hand remained constant with all groups averaging 1
(±1). This data suggests that the use of the IMAK gloves may increase the pain experienced
when used in the dominant hand whereas the use of the Veturo gloves may not increase or
decrease the pain experienced when completing the picking up coins test.
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Figure 62: Average Pain for Picking Up Coins
5.4.1.10 Lifting Cans Pain
As seen in the below Figure 63, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. On average, the
levels of pain reported by the subjects showed that the most amount of pain was experienced
when using the IMAK gloves (3 ±3) while the other groups were reported to experience a level
of 2 (±2). This suggests that the use of the IMAK gloves may increase the pain experienced
while the use of the Veturo gloves may not increase or decrease the pain experienced.
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Figure 63: Average Pain for Lifting Cans
5.4.1.11 Pouring Water Pain
As seen in the below Figure 64, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The self-reported
pain experienced when pouring water was once again relatively low, with the highest being
experienced during the IMAK intervention (2 ±1). Therefore, the data suggests that the use of the
IMAK gloves may increase the self-reported pain experienced by users while the Veturo gloves
may not increase or decrease the pain experienced when completing the pouring water test.
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Figure 64: Average Pain for Pouring Water
5.4.2 Range of Motion Tasks
5.4.2.1 Finger Metacarpophalangeal Flexion and Extension Pain
As seen in the below Figure 65 the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. Similar to
previous results, the dominant hand (right) was reported to experience more pain than the nondominant (left) hand. The self-reported pain experienced while performing the finger
metacarpophalangeal flexion and extension was relatively low with the highest scores reporting
from the right hand during the placebo and IMAK groups (2 ±1). This data suggests that the use
of the IMAK gloves in the dominant hand may increase pain experienced while the use of the
Veturo in both the dominant and non-dominant hand may not increase pain experienced.
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Figure 65: Average Pain for Finger Metacarpophalangeal Flexion and Extension
5.4.2.2 Finger Proximal Interphalangeal Flexion and Extension Pain
As seen in the below Figure 66, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. Once again, the
pain reportedly experienced in the dominant hand was greater than the pain in the non-dominant
hand however, both hands remain relatively low on the pain scale. Within both hands, the Veturo
gloves were shown to have lower pain experienced (1 ±1 in the right hand and 0 ±1 in the left
hand) when compared to the other groups. This information implies that the use of the Veturo
gloves may decrease the self-reported pain experienced when performing finger proximal
interphalangeal flexion and extension.
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Figure 66: Average Pain for Finger Proximal Interphalangeal Flexion and Extension
5.4.2.3 Thumb Carpometacarpal Abduction and Adduction Pain
As seen in the below Figure 67, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. The self-reported
pain experienced when performing thumb carpometacarpal abduction and adduction was fairly
low with a narrow range of most average scores. The IMAK gloves in the right hand were the
only exception with an average score of 2 (±1) compared to the 1 (±1) of all other scores in both
hands. This data suggests that the use of the IMAK gloves in the dominant hand may increase the
pain experienced during the thumb metacarpophalangeal abduction and adduction exercises.
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Figure 67: Average Pain for Thumb Carpometacarpal Abduction and Adduction
5.4.2.4 Thumb Metacarpophalangeal Flexion and Extension Pain
As seen in the below Figure 68, the average scores of all subjects were calculated based
on the individual self-reported pain using the Rheumatoid Arthritis Pain Scale. It can be seen that
overall the dominant (right) hand was self-reported to cause more pain than the non-dominant
(left) hand. In the dominant hand, the Veturo gloves were shown to cause the least amount of
pain (1 ±1). The IMAK gloves were once again shown to be associated with the most pain in the
non-dominant hand (2 ±1) while the Veturo gloves remained equal to the control (1 ±1). This
information implies that the use of the Veturo gloves on the dominant hand may decrease the
pain experienced while the use of the IMAK gloves on the non-dominant hand may increase the
pain experienced during the thumb metacarpophalangeal flexion and extension exercise.
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Figure 68: Average Pain for Thumb Metacarpophalangeal Flexion and Extension
5.5 Additional Outcome Measures
5.5.1 Temperature
After each task in both the Arthritis Hand Function Test and the range of motion
exercises, the temperature of the subject’s palm was recorded using a laser thermometer.
Depending on the task, unilateral or bilateral, temperature was recorded on the appropriate
hand(s).
5.5.1.1 Arthritis Hand Function Test
5.5.1.1.1 Grip Strength Temperature
As seen in the below Figure 69, the average scores of all subjects were measured using
the laser thermometer. The average palm temperature during the grip strength test was highest in
the control group by a maximum of 3°F when compared to the intervention groups. The
intervention groups all averaged a lower temperature than the control for both hands during the
grip strength task, with the Veturo gloves lower than the IMAK in the left hand (83°F ±7°F
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versus 84°F ±7°F). This data suggests that the use of either orthosis may not increase the palm
temperature during the grip strength portion of the AHFT.
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Figure 69: Average Temperature During Grip Strength
5.5.1.1.2 2-Point Pinch Strength Temperature
As seen in the below Figure 70, the average scores of all subjects were measured using
the laser thermometer. Similar to grip strength, 2-point pinch strength palm temperatures were
highest during the control. The differences between the control and the intervention groups was
most apparent with the placebo glove in the right hand (87°F ±7°F versus 84°F ±6°F) but was
also visible between both the orthoses and the control. This information implies that the use of
the IMAK or Veturo orthoses may decrease the palm temperature when performing the 2-point
pinch strength task.
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Figure 70: Average Temperature During 2-Point Pinch Strength
5.5.1.1.3 3-Point Pinch Strength Temperature
As seen in the below Figure 71, the average scores of all subjects were measured using
the laser thermometer. The difference in palm temperature was much more visible in the left
hand, rather than the right, during the 3-point pinch strength test. The largest difference amongst
temperatures in the left hand was between the placebo (82°F ±6°F) and the control (86°F ±6°F).
In both the right and left hands, the Veturo gloves were recorded to have the lowest palm
temperature (84°F ±6°F and 83°F ±6°F respectively). This data suggests that the use of either the
IMAK or Veturo orthoses may decrease the palm temperature during the 3-point pinch strength
portion of the AHFT.
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Figure 71: Average Temperature During 3-Point Pinch Strength
5.5.1.1.4 Pegboard Dexterity Temperature
As seen in the below Figure 72, the average scores of all subjects were measured using
the laser thermometer. Similar to previous temperature results, the left hand had a slightly lower
temperature in each group. Within the right hand, the placebo and Veturo gloves were recorded
to have the lowest temperature (84°F ±6°F for each) while the control was recorded to have the
highest (86°F ±7°F) followed by the IMAK (85°F ±7°F). The control remained the highest in the
left hand (85°F ±7°F) while the placebo group had the lowest recorded average temperature
(82°F ±6°F). The IMAK and Veturo gloves were recorded to have the same average temperature
in the left hand; 84°F (±7°F for IMAK and ±6°F for Veturo). This data suggests that the use of
either orthosis may decrease the palm temperature in the dominant and non-dominant hands
when compared to the control.
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Figure 72: Average Temperature During Pegboard Dexterity Test
5.5.1.1.5 Shoe Lacing Temperature
As seen in the below Figure 73, the average scores of all subjects were measured using
the laser thermometer. Keeping in mind the previous temperatures of tests such as the 2-point
pinch strength and pegboard dexterity, the variation of palm temperature remains fairly small.
Within the shoe-lacing test, the placebo was found to have the lowest recorded temperature at
83°F (±6°F) followed closely by the Veturo gloves at 84°F (±6°F). The control group continued
to have the highest average temperature at 86°F (±7°F) while the IMAK averaged 85°F (±7°F).
This information implies that while both orthoses may decrease the temperature, the use of the
Veturo orthoses may decrease the average palm temperature more so than the IMAK.
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Figure 73: Average Temperature During Shoe Lacing Test
5.5.1.1.6 Button Board Temperature
As seen in the below Figure 74, the average scores of all subjects were measured using
the laser thermometer. The control group remained to be the highest recorded temperature (86°F
±8°F) followed closely by the IMAK gloves (85°F ±7°F). The placebo and Veturo gloves
averaged the same palm temperature of 84°F (±6°F) during the button board test. This data
suggests that the use of either the IMAK or Veturo gloves may decrease the average palm
temperature during the button board portion of the AHFT.
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Figure 74: Average Temperature During Button Board Test
5.5.1.1.7 Safety Pin Fastening Temperature
As seen in the below Figure 75, the average scores of all subjects were measured using
the laser thermometer. Similar to previous palm temperature results, the control had the highest
recorded temperature (86°F ±8°F) followed by the IMAK gloves (85°F ±7°F). The placebo and
Veturo gloves both averaged a palm temperature of 84°F (±7°F). This information suggests that
the use of either the IMAK or Veturo gloves may decrease the palm temperature and possibly
that the Veturo gloves may decrease the temperature more so than the IMAK.
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Figure 75: Average Temperature During Safety Pin Fastening Test
5.5.1.1.8 Cutting Putty Temperature
As seen in the below Figure 76, the average scores of all subjects were measured using
the laser thermometer. As seen previously, the control had the highest recorded temperature
(86°F ±7°F) followed by the IMAK gloves (85°F ±8°F). The placebo and Veturo gloves both
averaged a palm temperature of 84°F (±7°F). This information suggests that the use of either the
IMAK or Veturo gloves may decrease the palm temperature and possibly that the Veturo gloves
may decrease the temperature more so than the IMAK.
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Figure 76: Average Temperature During Cutting Putty Test
5.5.1.1.9 Picking Up Coins Temperature
As seen in the below Figure 77, the average scores of all subjects were measured using
the laser thermometer. In both the right and left hands, the control maintained an average palm
temperature of 87°F (±6°F) and the Veturo maintained an average palm temperature of 84°F
(±6°F). The placebo and IMAK fluctuated slightly, but the individual differences remained
within 2°F. This data indicates that the use of either orthoses, IMAK or Veturo, may decrease the
average palm temperature when completing the coin pick up portion of the AHFT.
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Figure 77: Average Temperature During Picking Up Coin Test
5.5.1.1.10 Lifting Cans Temperature
As seen in the below Figure 78, the average scores of all subjects were measured using
the laser thermometer. The palm temperatures of both hands during the lifting cans test
continued the pattern of the control being the highest temperature (87°F ±7°F). The Veturo,
having had the lowest temperature of 84°F (±7°F), was 3°F lower than the control. The placebo
and IMAK averaged the same palm temperature during the lifting cans test at 86°F (±8°F and
±7°F respectively). This information suggests that the use of either the IMAK or Veturo gloves
may decrease the palm temperature during this portion of the AHFT.
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Figure 78: Average Temperature During Lifting Cans Test
5.5.1.1.11 Pouring Water Temperature
As seen in the below Figure 79, the average scores of all subjects were measured using
the laser thermometer. The pouring water test was the first instance of the IMAK gloves having
the lowest average temperature at 84°F (±7°F). The control remained the highest average
temperature at 86°F (±7°F) and the placebo and Veturo continued to be the same at 85°F (±8°F
and ±5°F respectively). This data suggests that the use of either the IMAK or Veturo orthoses
may decrease the average palm temperature while performing the pouring water test.
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Figure 79: Average Temperature During Pouring Water Test
5.5.1.2 Range of Motion
5.5.1.2.1 Finger Metacarpophalangeal Flexion and Extension Temperature
As seen in the below Figure 80, the average scores of all subjects were measured using
the laser thermometer. Similar to the palm temperatures recorded during the AHFT, the control
was the highest average temperature recorded in both the right (87°F ±5°F) and left (87°F ±5°F)
hands. The placebo was the lowest in the right hand (84°F ±4°F) while the placebo, IMAK, and
Veturo were equally low in the left hand. This data suggests that the use of the IMAK or Veturo
orthoses may decrease the palm temperature during finer metacarpophalangeal flexion and
extension.
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Figure 80: Average Temperature During Finger Metacarpophalangeal Flexion and Extension
5.5.1.2.3 Finger Proximal Interphalangeal Flexion and Extension Temperature
As seen in the below Figure 81, the average scores of all subjects were measured using
the laser thermometer. The differences between groups were clearly seen during the proximal
interphalangeal flexion and extension movements. The control continued to be the highest
temperature in both hands (88°F ±6°F and 86°F ±5°F) while the Veturo was the lowest in the left
hand (83°F ±5°F). This information suggests that the use of the IMAK or Veturo gloves may
decrease the palm temperature when performing proximal interphalangeal flexion and extension.
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Figure 81: Average Temperature During Finger Proximal Interphalangeal Flexion and Extension
5.5.1.2.4 Thumb Carpometacarpal Abduction and Adduction Temperature
As seen in the below Figure 82, the average scores of all subjects were measured using
the laser thermometer. The variations between and within each hand were visible in the below
figure. The control continued to be the highest in each hand (87°F ±4°F and 86°F ±4°F) while
the placebo and Veturo were the lowest (84°F ±5°F and 83°F ±4°F). The IMAK was slightly
lower than the control and slightly above the placebo and Veturo in both hands (85°F ±5°F in the
right and 84°F ±6°F in the left). This data suggests that the use of either the IMAK or Veturo
orthoses may decrease the palm temperature, while the Veturo may decrease the temperature
more than the IMAK.
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Figure 82: Average Temperature During Thumb Carpometacarpal Abduction and Adduction
5.5.1.2.5 Thumb Metacarpophalangeal Flexion and Extension Temperature
As seen in the below Figure 83, the average scores of all subjects were measured using
the laser thermometer. The scores follow the trend previously seen in other range of motion and
AHFT exercises; higher control temperature and similar, lower intervention temperatures. This
information implies that the use of the IMAK or Veturo gloves may decrease the palm
temperature when performing metacarpophalangeal flexion and extension of the thumb.
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Figure 83: Average Temperature During Thumb Metacarpophalangeal Flexion and Extension
5.5.1.3 Temperature Variation
The palm temperature was recorded at the beginning of each trial, after the 20-minute
warm up period (for intervention groups), after each task or exercise, and after all tests had been
completed. For each trial, after performing all range of motion exercises and the Arthritis Hand
Function Test, the subjects were instructed to remove the orthosis immediately following the
temperature recording of the last test in order to obtain the palm temperature of their skin. This
was included because of a slight gap between the intervention material and the skin of the palm
causing concern of accurate temperature readings. As seen below in Figure 84, for each trial
there was an increase in the temperature recording after the last test and after removing the
orthosis. The largest increase was seen in the Veturo, which increases from 85°F to 89°F after
removing the gloves. This suggests that the actual palm temperature when using the Veturo
gloves may be higher than recorded.
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Figure 84: Average Temperature Variation Throughout Trials
5.5.2 Blood Oxygen Levels
Blood oxygen levels were measured using a pulse oximeter after each trial during the
Arthritis Hand Function Test. Only four of the five patients’ data is included in the below results
because only 12 of the 69 (19%) points of data were able to be collected for one of the subjects.
The patient’s nails were too long to allow for the pulse oximeter to be placed properly on a finger
and obtain an accurate reading.
5.5.2.1 Grip Strength Blood Oxygen Level
As seen in the below Figure 85, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. There
was very little difference between the left and right hand overall, with some slight variation
occurring in the right hand during the placebo trial. The Veturo gloves were shown to be higher
than the control (99% ±1% versus 98% ±2%) in the left hand while both the Veturo and IMAK
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gloves were less than the control (98% ±2% versus 99% ±1%)in the right hand. This data
suggests that the Veturo gloves may increase the blood oxygen level in the non-dominant hand.
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Figure 85: Average Blood Oxygen Level During Grip Strength Test
5.5.2.2 2-Point Pinch Strength Blood Oxygen Level
As seen in the below Figure 86, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
average blood oxygen level was highest in the control, IMAK, and Veturo in the right hand (98%
±1%) and highest in the placebo and IMAK in the left hand (98% ±2%). This information
suggests that the use of the IMAK or Veturo gloves may not increase or decrease the blood
oxygen level in the dominant hand while the use of the IMAK gloves may increase the blood
oxygen level in the non-dominant hand.
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Figure 86: Average Blood Oxygen Level During 2-Point Pinch Strength Test
5.5.2.3 3-Point Pinch Strength Blood Oxygen Level
As seen in the below Figure 87, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
placebo and IMAK gloves had a higher blood oxygen level than the control and Veturo in the
right hand (98% ±1% versus 97% ±1%) whereas the placebo, IMAK, and Veturo gloves were all
higher than the control in the left hand (98% ±1% versus 97% ±1%). This suggests that the use
of the IMAK gloves may increase the blood oxygen level in both hands while the use of the
Veturo gloves may increase the blood oxygen level in the non-dominant hand.
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Figure 87: Average Blood Oxygen Level During 3-Point Pinch Strength Test
5.5.2.4 Pegboard Dexterity Blood Oxygen Level
As seen in the below Figure 88, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
control and Veturo gloves were recorded to have the same average blood oxygen level (98%
±1%) in the right hand while the placebo and IMAK gloves were 1% lower at 97% ±1%.
Alternatively, the control and placebo were the same in the left hand (98% ±2%) while the
IMAK gloves were recorded to be on average 97% ±2% and the Veturo gloves 96% ±4%. This
data suggests that the use of the Veturo gloves may decrease the blood oxygen level in the nondominant hand while the use of the IMAK gloves may decrease the blood oxygen level in either
hand.
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Figure 88: Average Blood Oxygen Level During Pegboard Dexterity Test
5.5.2.5 Shoe Lacing Blood Oxygen Level
As seen in the below Figure 89, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. As
shown below, there were no differences in the average blood oxygen level during the shoe lacing
portion of the AHFT. Therefore, this data suggests that the use of the IMAK or Veturo gloves
may not increase or decrease the blood oxygen level during this test.
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Figure 89: Average Blood Oxygen Level During Shoe Lacing Test
5.5.2.6 Button Board Blood Oxygen Level
As seen in the below Figure 90, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. Similar
to previous tasks, the difference between the highest and lowest average blood oxygen level was
narrow at 1%. The only group that was not at 98% ±1% was the IMAK at 97% ±1%. Therefore,
this information implies that the use of the IMAK gloves may decrease the blood oxygen level
while the use of the Veturo may not increase or decrease the blood oxygen level during the
button board test.

116

Button Board Blood Oxygen Level
101

Blood Oxygen (%)

100
99
98

98

98

98

Control
Placebo

97

97

IMAK
Veturo

96
95
94

Figure 90: Average Blood Oxygen Level During Button Board Test
5.5.2.7 Safety Pin Fastening Blood Oxygen Level
As seen in the below Figure 91, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
blood oxygen level remained at 98% ±1% during the control, placebo, and IMAK groups. The
Veturo was averaged at 97% ±2%, 1% lower than the control. This data implies that the use of
the IMAK gloves may not increase or decrease the blood oxygen level while the Veturo gloves
may decrease the blood oxygen level.
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Figure 91: Average Blood Oxygen Level During Safety Pin Fastening Test
5.5.2.8 Cutting Putty Blood Oxygen Level
As seen in the below Figure 92, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
average blood oxygen level remained constant within the control, placebo, and IMAK groups
(98% ±2%) but increased in the Veturo group (99% ±1%). This suggests that the use of the
Veturo gloves may increase the blood oxygen level during the cutting putty test while the use of
the IMAK may not increase or decrease the blood oxygen level.
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Figure 92: Average Blood Oxygen Level During Cutting Putty Test
5.5.2.9 Picking Up Coins Blood Oxygen Level
As seen in the below Figure 93, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. There
was some variation when comparing the dominant (right) to the non-dominant (left) hands with
the lowest score from the right hand at 96% ±3% and the lowest from the left at 98% ±1%. The
IMAK was recorded as the having the lowest average blood oxygen level in the right hand (96%
±3%) yet the highest in the left hand (99% ±1%). Additionally, the Veturo gloves were recorded
to be lower than the control in the right hand (97% ±1% versus 98% ±1%) but equal in the left
hand (98% ±1%). This information implies that the use of both the IMAK and Veturo gloves
may increase or decrease the blood oxygen level during the picking up coins test.
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Figure 93: Average Blood Oxygen Level During Coin Pickup Test
5.5.2.10 Lifting Cans Blood Oxygen Level
As seen in the below Figure 94, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. Similar
to previous tests, the blood oxygen level of the control was highest at 99% ±2%. The IMAK was
recorded to have the lowest average blood oxygen level at 97% ±0% while the Veturo and
placebo groups were recorded as equally 98% ±1%. This data suggests that the use of the IMAK
or Veturo orthoses may decrease the blood oxygen level during the lifting cans portion of the
AHFT.
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Figure 94: Average Blood Oxygen Level During Lifting Cans Test
5.5.2.11 Pouring Water Blood Oxygen Level
As seen in the below Figure 95, the average scores of all subjects included were
calculated based on the individual blood oxygen level readings using the pulse oximeter. The
control and placebo were recorded to have equal average blood oxygen levels at 98% ±1% while
the IMAK gloves were recorded to have 96% ±2% and the Veturos 97% ±2%. This information
implies that the use of the IMAK or Veturo orthoses may decrease the blood oxygen level when
compared to the control in the pouring water portion of the AHFT.
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Figure 95: Average Blood Oxygen Level During Pouring Water Test
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CHAPTER 6: DISCUSSION

6.1 Data Discussion
During the Arthritis Hand Function Test, the use of the intervention groups (placebo,
IMAK, and Veturo) caused an increase in the time subjects needed to complete the given task at
hand. This can be seen in the results of every timed task within the AHFT. Within the two
orthoses tested, there are more instances of the Veturo gloves scoring higher than the IMAK on
tasks such as the cutting putty task where patients took an average of 52 seconds (± 29) when
using the IMAK gloves but only took 48 seconds (± 13) when using the Veturo gloves. This
pattern continued within the range of motion tasks where there were instances when the Veturo
gloves increased the average maximum joint angle. For example, during the left hand thumb
carpometacarpal abduction and adduction the Veturo gloves reached an average maximum angle
of 56° (± 16) compared to the control of 55° (± 17) and IMAK of 55° (± 16). This pattern of the
Veturo gloves performing better than the IMAK continues within the Rheumatoid Arthritis Pain
Scale, where the pain experienced by patients was consistently lower than the IMAK gloves
when subjects were wearing the Veturo. This can be seen during both the range of motion tasks
and the AHFT. For example, during the pegboard dexterity task of the AHFT the average pain
with the IMAK gloves in the right hand was 1.4 (± 1) and the left was 1.6 (± 1.6) while the
average pain with the Veturo gloves in the right hand was 0.6 (± 1) and the left was 0.6 (± 1).
There are less instances of the Veturo gloves having a higher average blood oxygen level when
compared to the IMAK gloves during the AHFT however, these instances are not scarce and as
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only four of the five data sets were able to be used for this data it should not dismiss previous
information supporting the use of the Veturo gloves over the IMAK gloves. Similarly, the
average temperatures when using the IMAK gloves were all higher than when using the Veturo
gloves. However, data suggests that this is due to the higher insulation within the Veturo gloves
as the temperature difference between the last test and after removing the gloves is higher for the
Veturo gloves (5°) than the IMAK gloves (4°).
Another pattern seen throughout most of this study was that the non-dominant (left) hand
scored better than the dominant (right) hand while having an overall lower temperature reading.
The left hand was shown to take less time performing the same tasks within the AHFT and reach
higher maximum joint angles during the range of motion exercises. For example, during the 2point pinch strength task the maximum force achieved for the dominant hand was an average of
5kg (± 2) while the maximum force achieved for the non-dominant hand was an average of 7kg
(± 3). This was also seen within the RAPS for both the range of motion tasks and the AHFT. An
example was during the finger metacarpophalangeal flexion and extension exercise when the
maximum average pain experienced in the dominant hand was 2 (± 1) while the maximum
average pain experience in the non-dominant hand was 1 (± 1). While the pattern of the nondominant hand scoring better is seen during these tests, it was also seen that the temperature of
the non-dominant hand was consistently lower than that of the dominant. For example, during
the grip strength task the maximum temperature of the non-dominant hand was 85.4°F (± 6.7)
while the maximum temperature of the dominant hand was 87.2°F (± 6.8). The only instance
where this pattern was not seen was during the collection of the blood oxygen level throughout
the AHFT. Both hands were equal, maintaining the same highs and lows during the trials.
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Throughout this pilot study it was seen that the Veturo gloves, although not always
performing better than the control group, did perform better than the IMAK gloves. This
performance was partnered with the pattern of the non-dominant hand resulting in better
outcomes than the dominant hand, which was shown to cause more pain and function at a higher
temperature.
6.2 Study Design Modifications
Possible study design modification outside of the limitations discussed later in this
chapter are focused on increasing the complexity and difficulty of certain activities of daily
living tested in the Arthritis Hand Function Test. During the picking up coins test, all four coins
were placed individually on the table next to the coin box and participants were instructed to pick
up one at a time. Feedback from subjects suggests that the test would be much more difficult, if
not impossible, if the coins were stacked. In addition, feedback from participants suggests that
milk cartons or bottles large in diameter and without a handle would be much more difficult
when compared to the pitcher with a handle used in the pouring water test. Although these were
the only design suggestions based off of feedback from patients, additional design modifications
may be made with insight from more people with rheumatoid arthritis.
This pilot study is fairly unique in that there are very few previously conducted studies
focusing on the evaluation of thermal therapy orthoses. The only similar study was conducted in
2016 by the Centre for Health Sciences Research at the University of Salford. This study
examined the effects of orthoses worn at night by patients with rheumatoid arthritis and hand
osteoarthritis. Although similar in that both this study and the one conducted at the University of
Salford looked at outcomes such as pain and dexterity, the University of Salford study only had

125

their subjects wearing the orthoses at night [36]. Implementing the orthoses being worn at night
is another potential study design modification when conducting a long-term research study.
6.3 Orthoses Design Suggestions
The orthoses tested in this study are already a minimalistic design in that they are
compression gloves without any assistive technology incorporated. This allows for users to
experience as few limitations as possible with respect to overall hand function and range of
motion. Since the IMAK gloves tended to score more poorly than the Veturos, it is suggested
that these orthoses change the material that they are made of to one that is more conducive to the
desired effect of the gloves. The inclusion of copper woven fabric was initially considered as
there are studies showing their effectiveness [24, 25] however, more recent and extensive studies
show that the treatment of RA with copper does not provide any advantage [54]. Therefore, it is
suggested that orthoses made of more heat-generating material, such as thermal fabric as
opposed to the cotton-spandex blend of the IMAK Arthritis Gloves. The Veturo orthoses are
made of a polyethylene terephthalate material, trademarked as Celliant, which has been shown to
have a positive effect on chronic pain when used in clothing such as socks [55]. This thermal
material contains a polyester fiber infused with natural minerals such as aluminum oxide, quartz,
and titanium dioxide [56]. Additional research is needed on these orthoses as they are equipped
with material previously shown to have positive effects on patients suffering from symptoms
similar to those of rheumatoid arthritis. Based on the results of this study, no other design
modifications were deemed necessary.
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6.4 Clinical Context
Additional studies and information needs to be obtained prior to physicians prescribing
these orthoses to their patients with rheumatoid arthritis. Specifically, the long-term effects of the
gloves and their advantages or disadvantages on patients outside of stage 2. For example, studies
focusing on the potential of orthoses to delay the progression of the disease should be taken into
consideration. The work conducted in this study will contribute to the understanding of aids to
symptoms of rheumatoid arthritis and the level of effectiveness of certain orthoses. Also, the
limitations of these orthoses, such as the IMAK gloves not increasing the temperature enough to
aid the user, can be taken into consideration for new orthoses designed to better assist the user.
6.5 Power Analysis
A power analysis was performed in order to determine the optimal number of participants
for future studies [53]. The analysis was performed using the average palm temperature of the
control and Veturo orthoses. Temperature was chosen as this is the leading cause of the
decreased swelling and decreased pain experienced when using the orthoses as claimed by the
manufacturers. Additionally, temperature is recorded during both the Arthritis Hand Function
Test and during the range of motion exercises and is therefore, a constant outcome measure
throughout this pilot study. Pain, although constantly recorded, was not chosen because it is a
self-reported score. The following equation was used to perform the test:
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The hypotheses to be tested are H0: µControl = µVeturo and HA: µControl ¹ µVeturo. The
significance level of 0.05 will be used and a power of 0.8 to determine an absolute difference in
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the average temperature of at least 2°F. The standard deviation of the palm temperature is
believed to be no more than 3°F.
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Therefore, at least 18 patients need to be enrolled in the study in order to be able to detect
these desired results.
This power analysis does not include all aspects of this pilot study and it is recommended
that future studies perform analyses for every piece of information being collected in order to
make the best decision on the sample size.
6.6 Study Limitations
This pilot study, although providing new insight into the use of wrist-hand orthoses by
subjects with rheumatoid arthritis, has some limitations. First, this study consisted of all female
patients who were right-hand dominant. Four of these patients were between the ages of 56 and
69. This study did not include male patients, left-handed patients, or patients over the age of 69.
Future studies will need to have an array of ages, an array of dominant hands, and patients who
are both male and female. Also, this study only focused on patients categorized as having stage 2
rheumatoid arthritis and did not analyze patients categorized as stage 1, 3, or 4. Lastly, all
participants were only present for one day of trials. This did not allow for an adequate amount of
information to be gathered regarding the long-term effects of the gloves.
Additionally, during the palm temperature readings, the orthoses were not directly against
the skin of the palm. Although the palm temperature after removing the orthoses was recorded
and visible, the difference between the last test reading and the temperature after removing the
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gloves was not found to be significant (see Chapter 5.5.1.3). This temperature variation may be
determined to be significant for other studies and should continue to be monitored.
During the range of motion exercises, the Vicon Motion Capture system was used to
collect the movement data. After collection, it was determined that numerous markers were
missing from many of the frames within each trial. Although the system is programmed to
interpolate the positions of the missing markers, this does not ensure 100% accuracy especially
when upwards of 10% of a trial is theorized.
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CHAPTER 7: OBSERVATIONS
Throughout the testing and data collection process, a number of qualitative observations
were made that were important to the study. These observations, although not quantitatively
applicable to the conclusion, are significant in that some could help in explaining certain results
and others could aid future studies in this subject area.
The first observation was made regarding the attire of all subjects who participated in this
study; they wore shoes without laces and, all but one patient, shirts without buttons. After
inquiring about their daily lives and performing parts of the Arthritis Hand Function Test, it was
ascertained that the lack of shoe laces and buttons was not coincidental. On a daily basis, the
subjects participating in this study did not wear clothing that had laces or buttons because it was
too difficult and too discouraging for them to constantly struggle with these types of apparel.
This could have had an influence on the results of the button board and shoe-lacing tasks within
the AHFT; if the participants do not perform certain activities of daily living on a routine basis,
they are no longer activities of daily living and would cause the time to completion to be longer
than expected.
Another observation was made during the completion of the AHFT with two of the five
subjects. Both of their fingernails were longer than those of the other patients and seemed to
make tasks such as the coin pick-up and pegboard dexterity tests easier. The longer nails were
used to pick-up the coins and pegs without much use of the fingers and joints affected by
rheumatoid arthritis. This being said, their long fingernails also seemed to be a hindrance during
other tasks such as the button board test and shoe lacing test. Although not quantitatively
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applicable, this observation could have an effect on the overall results of these individual tests.
Based on this observation, it is suggested that future studies consider long fingernails as an
excluding factor in order to secure veracity.
Similar to the long finger nails, it was observed that there were instances where the
orthoses, specifically the placebo gloves, got in the way of the subject completing a task. This
was most clear during the safety pin fastening test when multiple patients fastened together tips
of the gloves with the cloth. Since this would not classify as a correct performance of the AHFT,
these instances were not recorded and were repeated to ensure accuracy.
It was also observed that as the trials progressed, the ability of the subject to complete a
task and the pain associated with the task improved. This could have been due to the fact that
subjects all began testing during the morning and as the day progressed, their morning stiffness
dissipated which allowed them better overall hand function. Additionally, as each trial
progressed patients became more familiar with the motions and tasks they were asked to
complete. This may have caused patients to become more confident in their abilities as they were
familiarized with the tests.
During the first trial of the lifting cans task in the AHFT, one 10.5oz soup can was
initially placed on the tray and the subject was asked to lift the weighted tray. Once they had
done this, the patient was asked if they would like another can added. If they said yes, another
can was added and they were asked to perform the lifting exercise again. This was repeated until
the patient felt they could not add anymore cans or the maximum of 12 was reached. Once their
maximum number was reached during the first trial, the subsequent trials immediately began at
this number and did not start at the beginning. For example, if patient X was able to lift all 12
cans during the first trial, the following trials began with them lifting all 12 cans as opposed to
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beginning with 1 and working their way back up to 12 cans. This was done to prevent fatigue
and to decrease pain related to this unnecessary repetitive motion. However, during the first trial
of adding a single can at a time, it was observed that patients became more fatigued and
disconcerted during the repetitive motion. This could have affected their ability to reach their
maximum number and more importantly, objectively report the pain associated with only the last
(maximum number of cans) lift.
Some patients reported that they had more severe pain elsewhere, whether from arthritis
or another disease. This could have affected their ability to accurately gauge the pain in their
hands when performing the range of motion tasks or AHFT. The ambient pain would not only
make it difficult to isolate the pain associated with only their hands but may also make the pain
from their RA in their hands and fingers seem less severe than it actually is. This could have
caused the recorded pain data to be less accurate than preferred.
In addition to performing tasks that they specifically avoided (button board and shoelacing) by wearing alternate clothing, patients also admitted to completing other tasks within the
AHFT that they do not attempt at home. Participants verbalized that they felt they could fulfill
these tasks, such as the cutting putty and lifting the weighted tray, because of the orthoses, even
with the placebo orthosis. This therefore presents a possible psychological influence of the
orthoses that causes patients to become more confident in themselves and attempt tasks they
otherwise would not. One such psychological explanation is the well-known placebo effect
referring to the “positive cognitive modulation of behaviors and outcomes related to medical
treatment” [57]. The combined outcome of the placebo effect and patient expectancy, the belief
that the intervention will help, is common within the medical industry, especially with respect to
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pain [58]. The placebo effect, along with patient expectancy, may explain why patients felt they
could successfully perform tasks that they otherwise felt too daunting to take on.
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CHAPTER 8: CONCLUSION

8.1 Patient History Survey and Pain Catastrophizing Scale
8.1.1 Patient History Survey
The patient history survey, with the Health Assessment Questionnaire incorporated [2],
was given to participants prior to the start of the first trial. This survey gathered information
about the health and well-being of each subject in addition to their pain levels when completing
specific activities of daily living. Patients varied slightly however; overall, participants indicated
that in spite of the numerous activities of daily living affected by their RA (63 out of 120), four
of the five patients self-reported that they were in “very good” health and that their RA affects
them, on average, 53% of the time. Patients were also affected by other health factors, such as
heartburn and mouth sores, 32% of the time. This self-reported data suggests that the participants
of this study may be moderately affected by their RA but may still have been able to lead
independent lives.
8.1.2 Pain Catastrophizing Scale
As part of the personal history survey, subjects were asked to complete the Pain
Catastrophizing Scale (PCS) [3]. This scale was used to determine the psychological effect of
pain on each of the subjects. Within this study, patients fell at or below the 50th percentile of the
PCS. This information implies that the participants of this study may not focus on their pain or
allow it to affect them in a severely catastrophic manner psychologically.
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8.2 Arthritis Hand Function Test
The Arthritis Hand Function Test was used to evaluate strength, dexterity, and overall
function of the hands through a number of tasks [4]. Patients performed the entire test with the
control, placebo, IMAK and Veturo orthoses and adhered to the test manual instructions for
proper form and completion. After scoring and analyzing the results, it was determined that there
were slight differences in the form of subjects requiring more time to complete certain tasks
when using the orthoses or placebo when compared to the control. Within both of the orthoses
tested, the Veturo glove scored consistently better than the IMAK. Therefore, this data suggests
that while the use of orthoses may cause users to take more time to complete certain tasks, the
use of the Veturo gloves may be more advantageous than the use of the IMAK gloves.
8.3 Range of Motion Tasks
Four range of motion tasks were used to evaluate the overall movement capabilities of the
participants [9]. These motions were recorded using the Vicon Nexus motion capture system and
analyzed using the C-Motion Visual 3D software. The average movements along with the
maximum joint angles reached were all compared to determine if the differences were
statistically significant. As there were some instances where the orthoses performed better than
the control and placebo groups, it is implied that the use of the IMAK or Veturo orthoses may
increase the range of motion potential of the user.
8.4 Pain Scale
During the course of this study, in conjunction with the Arthritis Hand Function Test and
the range of motion tasks, subjects were asked to rate the pain experienced when performing
each individual activity using the Rheumatoid Arthritis Pain Scale [10]. The scores were
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compared and it was determined that the orthoses did provide relief by means of consistently
having lower pain score results than the control or placebo groups. Within the two orthoses, the
Veturo gloves were shown to have lower self-reported pain scores than the IMAK gloves. This
data suggests that the use of orthoses may decrease the self-reported pain experienced by patients
during the AHFT and range of motion tasks. It is also implied that between the two orthoses
tested, the Veturo gloves may decrease the pain experienced more so than the IMAK gloves.
8.5 Additional Outcome Measures
8.5.1 Temperature
Throughout the range of motion exercises and the Arthritis Hand Function Test, the
temperature of the palm of the hand(s) was recorded to analyze the differences between using
and not using the gloves. Temperature was recorded in order to assist in the measuring of blood
flow and therefore, inflammation. During all of these exercises a pattern was identified where the
non-dominant (left) hand functioned at a consistently lower temperature than the dominant
(right) hand. Additionally, the temperature readings with the orthoses were much lower than the
control group however, the temperature readings taken immediately after the gloves were
removed were much higher than the temperature of the control. This information implies that the
use of the thermal therapy gloves may increase the hand temperature as seen when comparing
the readings taken after removing the gloves. Future studies should consider other forms of
inflammation monitoring such as ultrasound in order to achieve the most accurate results
possible.
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8.5.2 Blood Oxygen Level
During each performance of the Arthritis Hand Function Test, the blood oxygen level
was recorded after each individual task. This information was compared within each test, for
example; within the right-hand pegboard dexterity the placebo, IMAK, and Veturo were all
compared to the control. The blood oxygen levels were not found to have a discernable pattern
and remained fairly equal, within each hand and when comparing both hands, throughout this
pilot study. Therefore, the data suggests that the use of the thermal therapy orthoses may not
increase or decrease the blood oxygen levels in the hands when performing the Arthritis Hand
Function Test.
8.6 Specific Aims
Aim 1: Determine if each thermal therapy arthritic glove increases range of motion in patients
by comparing the performance with and without the orthoses [8, 9].
The Veturo gloves were shown to increase the maximum joint angles more so than the
IMAK gloves. Although this was not consistent throughout all four exercises, it is suggested that
the use of thermal therapy arthritis gloves may increase range of motion in patients with stage 2
RA.
Aim 2: Determine if each thermal therapy arthritic glove decreases the amount of pain
experienced by the patient when completing specific tasks using the Rheumatoid Arthritis Pain
Scale [10].
Throughout both the AHFT and the range of motion exercises, it was shown that the selfreported pain experienced by the participants was less when using a thermal therapy arthritis
glove. Between the two orthoses tested, the Veturo gloves consistently scored lower on the
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RAPS when compared to the IMAK gloves. This information implies that the use of the Veturo
thermal therapy gloves may decrease the amount of pain experienced by patients when
completing specific tasks using the Rheumatoid Arthritis Pain Scale.
Aim 3: Determine if each thermal therapy arthritic glove increases hand strength, dexterity and
overall function using the Arthritis Hand Function Test [4].
During the Arthritis Hand Function Test there were few instances where the orthoses
scored better than the control. Most, if not all, of the time it was seen that the gloves caused a
hindrance which led to the patient needing longer to complete the tasks. As 55% of the Arthritis
Hand Function Test is scored based on the amount of time needed to successfully finish a test, it
cannot be said that the orthoses scored better than the control. Consequently, this information
implies that neither the IMAK nor the Veturo orthoses may increase hand strength, dexterity, or
overall function during the Arthritis Hand Function Test.
Aim 4: Determine the advantages and disadvantages of each thermal therapy arthritic glove by
comparing the results of each test.
Based on the results of the Arthritis Hand Function test, one of the disadvantages of the
thermal therapy orthoses is that they increase the amount of time needed to complete a certain
task, such as buttoning clothes or lacing a shoe. Alternatively, it was observed within the AHFT
that subjects were attempting tasks they otherwise would not because of the expectation that the
orthoses would make it possible for them to complete these activities. Although additional
research needs to conducted, an advantage of the orthoses observed within the study was the
added psychological confidence needed to complete tasks subjects deemed impossible.
Additionally, throughout this pilot study it was shown that the use of the thermal therapy arthritis
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gloves decreases the pain experienced by participants. This data suggests that while the use of
orthoses may cause a need for an increased amount of time to complete activities of daily living,
the gloves could provide a psychological advantage while possibly decreasing the overall pain
experienced by the user.
8.7 General Conclusion
This study evaluated the overall hand function and ranges of motion in order to determine
if the IMAK Arthritis Gloves and the Veturo Therapy Infrared Gloves aided the user by treating
symptoms such as swelling and pain. Thermal therapy orthoses have been used by patients to
treat these and similar symptoms in order to improve overall hand function and increase their
independence [35]. The differences in the performances of each orthosis were visible throughout
the study and showed that the use of the thermal therapy gloves may be advantageous to patients
with stage 2 rheumatoid arthritis. While a visible difference in outcome measure from both the
IMAK and Veturo gloves was seen throughout this pilot study, the IMAK Arthritis Gloves did
not perform as well as the Veturo Therapy Infrared Gloves. The data suggests that although
further research is needed into the long-term effects of these orthoses, the Veturo Therapy
Infrared Gloves may be beneficial by reducing pain and increasing range of motion in users. In
conclusion, this pilot study gave insight into the advantages and disadvantages of wrist-hand
orthoses used to treat symptoms of rheumatoid arthritis and will provide a foundation for future
studies.
8.8 Future Studies
This pilot study is meant to serve as a basis to design future experiments focusing on the
use of thermal therapy orthoses by patients with rheumatoid arthritis in their hands. There are
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multiple avenues for additional studies based off of this initial experiment, all of which will serve
as influential research for this new field.
It is recommended that longer durations of use be tested in order to determine any longterm effects of thermal orthoses. By having participants use the orthoses for an extended period
(i.e. 6 months) and coming in for multiple evaluations, the durability and lasting effect of thermal
orthoses can be measured. Additionally, the combination of newly prescribed pharmaceutical
interventions coupled with the use of orthoses can be tested in order to assist in determining the
best course of treatment on an individual basis. This could also be done with the combination of
different orthoses; static at night, as these have previously been shown to be helpful to patients
with RA, and therapy gloves during the day. Lastly, further research should be pursued focusing
on the psychological aspect of the use of these orthoses. It was seen in this study that patients
were successfully completing tasks that they otherwise would not attempt because of their
expectations of the orthoses. This, along with their perception of pain, are extensive influencers
in the medical field. In conclusion, more information on the longstanding effects of thermal
therapy orthoses would need to be gathered prior to clinicians prescribing these to their patients
however, the personal account of users who have had success with these orthoses will continue
to be influential to others.
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APPENDIX A – PATIENT HISTORY SURVEY

Patient #

Personal History Survey
IRB Study # Pro00029570
The following survey is in regards to your personal, medical history. If at any time you have
questions or concerns, please bring them up to a member of the study team.
____________________________________

____________________________________

Last Name

First Name

_____________________

____________________

______________________

Birth Year

Gender

Year of RA Diagnosis

_____________________________________________________________________________
Medication Taken for Symptoms of RA
_____________________________________________________________________________
Orthoses (Braces) Used to Treat Symptoms of RA
_____________________________________

____________________________________

Phone Number

Email Address

The following Health Assessment Questionnaire (HAQ) will be used in conjunction with the
Arthritis Pain Scale.
_______________

________________

_______________

Average Daily Pain

Most Severe Pain

Least Severe Pain

My rheumatoid arthritis began with:
_____ a fever ____ an accident ____ other, describe _______________________
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My rheumatoid arthritis affects:
___ my fingers

___ my hands/wrists

___ my elbows

___ my shoulders

___ my neck

___ my back

___ my toes

___ my feet/ankles

___ my knees

___ my hips

My blood tests reveal:
Rf factor

___ Negative ___ Positive Titer

___ Not tested

Anti-CCP

___ Negative ___ Positive Titer

___ Not tested

HLA-DR4

___ Negative ___ Positive

___ Not tested

Who diagnosed your rheumatoid arthritis?
___ Primary Physician

___ Rheumatologist

___ Self

How did your arthritis affect your ability to carry out your daily life this week?
0 = can always complete with no difficulty, 2 = can usually do it, 4 = can sometimes do it but
usually have much difficulty, 6 = unable to do it
Dressing and Grooming: Are you able to:
Dress yourself including shoelaces and buttons _____
Shampoo your hair _____
Arising: Are you able to:
Stand up from a straight chair _____
Get in and out of bed _____
Eating: Are you able to:
Cut your meat _____
Lift a full glass to your mouth _____
Open a new milk carton _____
Walking: Are you able to:
Walk outdoors on flat ground _____
Climb 5 steps _____
Go down five steps _____
Walk on uneven ground _____
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Please check any aids or Devices that you usually use for any of the above activities:
___ Aids used for dressing (button hook, zipper pull)

___ Special/built up chair

___ Special/built up utensils ___ Cane

___ Crutches ___ Wheelchair

___ Walker

Please check any categories that you usually need help from another person:
___ Dressing and Grooming ___ Arising

___ Eating

___ Walking

How did your arthritis affect your ability to carry out your daily life this week?
0 = can always complete with no difficulty, 2 = can usually do it, 4 = can sometimes do it but
usually have much difficulty, 6 = unable to do it
Hygiene: Are you able to:
Wash and dry your body _____
Take a tub bath _____
Get on and off the toilet _____
Reach: Are you able to:
Reach above your head and get down a 5lb bag of sugar _____
Bend down to pick up clothing from the floor _____
Grip: Are you able to:
Open car doors _____
Open previously opened jars _____
Turn faucets on and off _____
Activities: Are you able to:
Run errands and shop _____
Get in and out of a car _____
Do chores such as vacuuming and yard work _____
Dance _____
Gold _____
Swim _____
Please check any aids or Devices that you usually use for any of the above activities:
___ Raised toilet seat

___ Bathtub set

___ Long handled appliances in bathroom

___ Bathtub bar
___ Long handled appliances for reach
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___ Jar opener (for previously opened jars)
Please check any categories that you usually need help from another person:
___ Hygiene ___ Reach

___ Grip

___ Activities

How’s your overall health?
In general, would you say that your overall health is:
___ excellent ___ very good

___ good

Morning Stiffness: Are you stiff in the morning?

___ fair

___ poor

___ Y ___ N

If yes, how long does the stiffness last: ___ hours ___ minutes
Pain: Please mark how much pain you have had in the last week:
Place a single vertical line ( | ) through the link to indicate the severity of pain.
None

Severe

0

100

When you wake up in the morning, do you ache?

___Y ___N

If yes, how long does your pain last? ___ hours ___ minutes
Do you take anything for the pain?

___ Y ___ N

If yes, please list with dosage: _____________________________________________________
Have you ever had any of these symptoms today, this past week, this past month?
General
Fever

___ today

___ this week

___ this month

Dizziness

___ today

___ this week

___ this month

Tiredness (fatigue)

___ today

___ this week

___ this month

___ today

___ this week

___ this month

Ringing in your ears ___ today

___ this week

___ this month

Head, eyes, nose, mouth, throat
Blurred vision
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Hearing difficulties

___ today

___ this week

___ this month

Mouth sores

___ today

___ this week

___ this month

Dry mouth

___ today

___ this week

___ this month

Loss/change in taste ___ today

___ this week

___ this month

Headache

___ today

___ this week

___ this month

Chest pain

___ today

___ this week

___ this month

Shortness of breath

___ today

___ this week

___ this month

Wheezing

___ today

___ this week

___ this month

Joint pain

___ today

___ this week

___ this month

Joint swelling

___ today

___ this week

___ this month

Leg/ankle swelling

___ today

___ this week

___ this month

Low back pain

___ today

___ this week

___ this month

Muscle pain

___ today

___ this week

___ this month

Neck pain

___ today

___ this week

___ this month

Weakness of muscles ___ today

___ this week

___ this month

Chest, lungs, heart

Musculoskeletal

Gastrointestinal tract
Loss of appetite

___ today

___ this week

___ this month

Nausea

___ today

___ this week

___ this month

Heartburn

___ today

___ this week

___ this month

Indigestion

___ today

___ this week

___ this month

Pain in stomach area ___ today

___ this week

___ this month

Liver problems

___ today

___ this week

___ this month

Lower abdomen pain ___ today

___ this week

___ this month

Diarrhea

___ today

___ this week

___ this month

Constipation

___ today

___ this week

___ this month

Black/tarry stools

___ today

___ this week

___ this month

Vomiting

___ today

___ this week

___ this month
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Neurological and Psychological
Sadness

___ today

___ this week

___ this month

Depression

___ today

___ this week

___ this month

Insomnia

___ today

___ this week

___ this month

Nervousness

___ today

___ this week

___ this month

Trouble thinking

___ today

___ this week

___ this month

Easy bruising

___ today

___ this week

___ this month

Hives/welts

___ today

___ this week

___ this month

Itching

___ today

___ this week

___ this month

Rash

___ today

___ this week

___ this month

Skin

Pregnancy
___ Y ___ N ___ NA
Eating Habits
Breakfast:
I usually eat a ___ hearty ___ light breakfast
I usually ___ do ___ do not snack before lunch
Lunch:
I usually eat a ___ hearty ___ light lunch
I usually ___ do ___ do not snack before dinner
Dinner:
I usually eat a ___ hearty ___ light dinner
I usually ___ do ___ do not snack before going to bed
Each week I usually eat:
___ servings of vegetables that are

___ conventional ___ organic

___ servings of fruits that are

___ conventional ___ organic

___ servings of proteins that are

___ conventional ___ organic

___ raw nuts
___ raw almonds
___ roasted nuts
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___ fat

___ olive oil

___ organic butter

___ conventional butter

___ sea salt

___ table salt

___ vegetable oils

___ hydrogenated oils

___ fish oil

___ fried foods
Changing:
I am changing __________________________________________________
I have been ____________________________________________________ daily for ___ today,
____ weeks, or ____ months
Water
I drank _____ glasses of water before. Now I drink ____ glasses of water daily.
The water I drink is: ___ tap

___ bottled (brand ________ or ____ mixed brands)

___ filtered

___ distilled

I exercise ___ daily

___ weekly

___ monthly

I

___ do yoga

___ water exercises

Exercise
___ walk

___ garden

___ dance

Other ______________________________________________________
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Y
Age:_____

Copyright Ó 1995
Michael JL Sullivan

PCS
Sex:

M(__)

F(__)

Everyone experiences painful situations at some point in their lives. These experiences may include
headaches, tooth pain, joint or muscle pain. People are often exposed to situations that may cause
pain such as illness, injury, dental procedures or surgery.
We are interested in the types of thoughts and feelings that you have when you are in pain. Thirteen
statements are listed below describing different thoughts and feelings that may be associated with
pain. Using the following scale, please indicate the degree to which you have these thoughts and
feelings when you are experiencing pain.

0 ‒ not at all 1 ‒ to a slight degree 2 ‒ to a moderate degree 3 ‒ to a great degree 4 ‒ all the time

When I’m in pain...
1

I worry all the time about whether the pain will end.

2

I feel I can’t go on.

3

It’s terrible and I think it’s never going to get any better.

4

It’s awful and I feel that it overwhelms me.

5

I feel I can’t stand it anymore.

6

I become afraid that the pain will get worse.

7

I keep thinking of other painful events.

8

I anxiously want the pain to go away.

9

I can’t seem to keep it out of my mind.

10

I keep thinking about how much it hurts.

11

I keep thinking about how badly I want the pain to stop.

12

There’s nothing I can do to reduce the intensity of the pain.

13

I wonder whether something serious may happen.

...Total

PCS - United States/English - Version of 24 April 17 - Mapi.
ID058127 / PCS_AU1.0_eng-US.doc
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APPENDIX B – ARTHRITIS HAND FUNCTION TEST (AHFT)
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APPENDIX C – RANGE OF MOTION TASKS

Figure 96: Metacarpophalangeal Flexion and Extension

Figure 97: Proximal Interphalangeal Flexion and Extension
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Figure 98: Carpometacarpal Abduction and Adduction

Figure 99: Thumb Metacarpophalangeal Flexion and Extension
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APPENDIX D – PAIN CATASTROPHIZING SCALE

APPENDIX A

PCS Raw Scores and Percentiles

31
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PCS Total

Rumination

Magnification

Helplessness

0
0
2
3

1

0

4
1
5
2
0
6
2
7
8

3

9
3
10
4
1
11
4
12

5

13
14
5
6
15
16
2
17

7

18
19
-20-

6

7

-8-

-3-
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-8-

Percentile
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
-50-

PCS Total

Rumination

Magnification

Helplessness

21
22

9

23
9
24

10

25
4
11
26

10

27
28
12

29
**30**

**11**

**5**

**13**

6

14

31
32
33

12

15
34
35
13

7

36
37

16
17

38
39
40
41
42
43
44
45
46
47-48
49-52

8
14
18
9
19
15
10
11
16

12
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20
21
22
23-24

Percentile
51
52
53
54
55
56
57
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59
60
61
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65
66
67
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69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
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PCS: English and French Versions
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APPENDIX E – COPYRIGHTS

Faculty of Medicine
Department of Occupational Science &
Occupational Therapy
T325 - 2211 Wesbrook Mall
Vancouver, BC Canada V6T 2B5
P: 604 822 7392 | F: 604 822 7624
os.ot@ubc.ca | www.osot.ubc.ca

MEMORANDUM
To:

Brittany Mott, Graduate Student
University of South Florida

From:

Catherine Backman, PhD, FCAOT
Professor

Date:

March 7, 2018

Re:

Reproduction of items Arthritis Hand Function Test (AHFT) Manual

This memorandum confirms permission for you to reproduce test items and/or assessment
forms from the AHFT Manual in your graduate thesis submitted to the University of South
Florida. Please acknowledge the source and permission, e.g.,
Reproduced from Backman, C., & Mackie, H. (1997). Arthritis Hand Function Test Manual.
Vancouver, BC. Available from The University of British Columbia Department of
Occupational Science & Occupational Therapy, www.osot.ubc.ca. With permission of the
authors.
You may reproduce the entire manual for sharing with a limited audience comprised of your
thesis supervisory/examining committee.
Please do not reproduce the manual in its entirety as part of a thesis that is made publicly
available, for instance, in your university’s library or repository of theses and dissertations.
Good luck with your project.
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User agreement
Special Terms
Mapi Research Trust, a non-for-profit organisation subject to the terms of the French law of 1st July 1901, registered in
Carpentras under number 453 979 346, whose business address is 27 rue de la Villette, 69003 Lyon, France, hereafter referred
to as “MRT” and the User, as defined herein, (each referred to singularly as a “Party” and/or collectively as the “Parties”), do
hereby agree to the following User Agreement Special and General Terms:
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
Recitals
The User acknowledges that it is subject to these Special Terms and to the General Terms of the Agreement, which are included
in Appendix 1 to these Special Terms and fully incorporated herein by reference. Under the Agreement, the Questionnaire
referenced herein is licensed, not sold, to the User by MRT for use only in accordance with the terms and conditions defined
herein. MRT reserves all rights not expressly granted to the User.
The Parties, in these Special Terms, intend to detail the special conditions of their partnership.
The Parties intend that all capitalized terms in the Special Terms have the same definitions as those given in article 1 of the
General Terms included in Appendix 1.
In this respect, the Parties have agreed as follows:

Article 1. Conditions Specific to the User
Section 1.01

Identification of the User

User Name

Mott Brittany

Legal Form

Student

Address

20041 Heritage Point Dr
Florida
33647 Tampa

Country

United States of America

Email address
Section 1.02
Title

bmott@mail.usf.edu
Identification of the Questionnaire
Pain Catastrophizing Scale (PCS)

Pain Catastrophizing Scale_UserAgreement_March2016_5.0
© Mapi Research Trust. The unauthorized modification and use of any portion of this document is prohibited.
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Author(s)

Sullivan Michael JL

Owner

Michael Sullivan (Canada)

Copyright

Copyright © 1995 Michael JL Sullivan. All right reserved

Original bibliographic references
Sullivan MJL, Bishop SR and Pivik J. The Pain Catastrophizing Scale: development and
validation. Psychological assessment. 1995;7(4):524-532 (abstract)

Article 2. Rights to Use
Section 2.01

Context of the Use of the Questionnaire

The User undertakes to only use the Questionnaire in the context of the Study as defined hereafter.
Context of Use

Other project

Title

Comparison of Thermal Glove Hand-Wrist Orthoses in Their Effectiveness on
Rheumatoid Arthritis

Disease or condition

Rheumatoid Arthritis

Start

11/2017

End

07/2018

Description of the project

This project hopes to determine the effectiveness of three different orthoses used by
patients with rheumatoid arthritis in their hands and is interested to see if the pain
behavior (using the PCS) of the subjects influences the outcome of the study.

Presentation format of project

Student Masters Thesis

Section 2.02

Conditions for Use

The User undertakes to use the Questionnaire in accordance with the conditions for use defined hereafter.
(a) Rights transferred
Acting in the Owner’s name, MRT transfers the following limited, non-exclusive rights, to the User (the “Limited Rights”)
(i) to use the Questionnaire, only as part of the Study; this right is made up exclusively of the right to communicate
it to the Beneficiaries only, free of charge, by any means of communication and by any means of remote distribution known or
unknown to date, subject to respecting the conditions for use described hereafter; and
(ii) to reproduce the Questionnaire, only as part of the Study; this right is made up exclusively of the right to
physically establish the Questionnaire or to have it physically established, on any paper, electronic, analog or digital medium, and
in particular documents, articles, studies, observations, publications, websites whether or not protected by restricted access, CD,
DVD, CD-ROM, hard disk, USB flash drive, for the Beneficiaries only and subject to respecting the conditions for use described
hereafter; and
(iii) Should the Questionnaire not already have been translated into the language requested, the User is entitled to
translate the Questionnaire or have it translated in this language, subject to informing MRT of the same beforehand by the
signature of a Translation Agreement indicating the terms of it and to providing a copy of the translation thus obtained as soon
as possible to MRT.
The User acknowledges and accepts that it is not entitled to amend, modify, condense, adapt, reorganise the Questionnaire on
Pain Catastrophizing Scale_UserAgreement_March2016_5.0
© Mapi Research Trust. The unauthorized modification and use of any portion of this document is prohibited.
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any medium whatsoever, in any way whatsoever, even minor, without MRT’s prior specific written consent.
(b)

Specific conditions for the Questionnaire

• Use in Individual clinical practice or Research study / project
User shall:
- Cite the reference publications
- never duplicate, transfer or publish the Questionnaire without indicating the Copyright Notice
- Insert the Owner’s copyright notice on all pages/screens on which the Questionnaire will be presented
- Mention the following information: “The Questionnaire contact information and permission to use: Mapi Research
Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org ”
- In case of use of an IT Company (e-vendor), User shall check with Mapi Research Trust that the IT Company has
signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire

In the case of use of an electronic version of the Questionnaire in academic studies, the User undertakes to respect the following
special obligations:
- Submit the screenshots of all the Pages where the Questionnaire appears to Mapi Research Trust before release for
approval and to check that the above-mentioned requirements have been respected.

In the case of use of an electronic version of the Questionnaire in commercial studies / projects, the User undertakes to respect
the following special obligations:
- For the first migration of the Questionnaire (generally the original version) into a specific electronic device
- Review of screenshots:
After implementation of the Questionnaire into the device, the user and/or IT Company will generate screen captures
(screenshots) of the original questionnaire as displayed in the device. These will be reviewed by Mapi to check that they are
consistent with the original paper version in terms of presentation, content and completion except for specific instructions related
to the electronic administration. Corrections that may be needed will be reported to the user and/or IT Company. In this case,
screenshots after correction will be generated for another round of review by Mapi until all screenshots are approved.
- Usability testing:
Usability testing is a methodology which aims to examine whether respondents are able to use a device and associated software
as intended. Major issues of concern in usability testing typically include device complexity, navigation and response selection for
example.
The objective of this investigation is to ensure that the electronic version of the questionnaire as included in the device meets
usability criteria, focusing on functional aspects and respondents’ understanding of instructions. Usability testing consists in
interviews with patients where patients will complete the electronic version of the Questionnaire on the device and comment on
their understanding of the instructions, ease of use and handiness of the device. A Usability testing report presenting results will
be produced. If any changes are recommended, these will be implemented by the user and/or IT Company. If issues raised by
respondents are rated as major, the user and/or IT Company may need to perform additional developments and another round of
interviews may be needed.
The review of screenshots is mandatory. The usability testing is highly recommended by Mapi, however should the User and/or
Pain Catastrophizing Scale_UserAgreement_March2016_5.0
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IT Company decide not to perform this step, Mapi Research Trust shall not be held responsible for any consequence and
expense associated with this decision which shall remain the User and/or IT Company’s sole liability.
The review of screenshots and usability testing, when and if performed, shall be performed exclusively by Mapi and shall be
sponsored by the User.
The performance of the review of screenshots and usability testing will result in a certification of the electronic device original
version of the Questionnaires by Mapi for future licenses.
- For the migration of other language versions of the Questionnaire on an existing certified specific electronic device
- Update version
After the electronic device original version of the Questionnaire is fully ready, the Questionnaire’s language versions developed
for paper administration will be updated to reflect the changes in wording of instructions implemented in the electronic device
original version of the questionnaire.
Native speakers of the languages will reflect the changes made to the electronic device original version of the Questionnaire and
will provide English equivalents of all changes made for Mapi’s quality control.
- Review of screenshots:
After implementation of the Questionnaire into the device, the user and/or IT Company will generate screen captures
(screenshots) of the original questionnaire as displayed in the device. These will be reviewed by Mapi to check that they are
consistent with the original paper version in terms of presentation, content and completion except for specific instructions related
to the electronic administration. Corrections that may be needed will be reported to the user and/or IT Company. In this case,
screenshots after correction will be generated for another round of review by Mapi until all screenshots are approved.
The update of version and review of screenshots are mandatory. These steps shall be performed exclusively by Mapi and shall
be sponsored by the User.
The performance of the update of version and review of screenshots will result in a certification of the electronic device language
version of the Questionnaires by Mapi for future licenses.
• Use in a publication or on a website with unrestricted access:
In the case of a publication, article, study or observation on paper or electronic format of the Questionnaire, the User undertakes
to respect the following special obligations:
- not to include any full copy of the Questionnaire, but a protected version with the indication “sample copy, do not
use without permission”
- to indicate the name and copyright notice of the owner
- to include the reference publications of the Questionnaire
- to indicate the details of MRT for any information on the Questionnaire as follows: contact information and
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
- to provide MRT, as soon as possible, with a copy of any publication regarding the Questionnaire, for information
purposes
- to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that
the above-mentioned requirements have been respected.
• Use for dissemination:
- On a website with restricted access:
In the case of publication on a website with restricted access, the User may include a clean version of the Questionnaire, subject
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to this version being protected by a sufficiently secure access to only allow the Beneficiaries to access it.
The User undertakes to also respect the following special obligations:
- to indicate the name and copyright notice of the owner
- to include the reference publications of the Questionnaire
- to indicate the details of MRT for any information on the Questionnaire as follows: contact information and
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
- to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that
the above-mentioned requirements have been respected.

- On promotional / marketing documents
In the case of publication on promotional/marketing documents, the User undertakes to respect the following special obligations:
- to indicate the name and copyright notice of the Owner
- to include the reference publications of the Questionnaire
- to indicate the details of MRT for any information on the Questionnaire as follows: contact information and
permission to use: Mapi Research Trust, Lyon, France – Internet: https://eprovide.mapi-trust.org/
- to provide MRT, as soon as possible, with a copy of any publication regarding the Questionnaire, for information
purposes
- to submit the screenshots of all the Pages where the Questionnaire appears to MRT before release to check that
the above-mentioned requirements have been respected.

For any other use not defined herein, please contact MRT for the specific conditions of use and access fees (if applicable).

Article 3. Term
MRT transfers the Limited Rights to use the Questionnaire as from the date of delivery of the Questionnaire to the User and for
the whole period of the Study.
Article 4. Beneficiaries
The Parties agree that the User may communicate the Questionnaire in accordance with the conditions defined above to the
Beneficiaries involved in the Study only, in relation to the Study defined in section 2.01.

Article 5. Territories and Languages
MRT transfers the Limited Rights to use the Questionnaire on the following territories and in the languages indicated in the table
below:
Questionnaire

Language
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PCS

English for the USA

Article 6. Price and Payment Terms
The User undertakes in relation to MRT to pay the price owed in return for the availability of the Questionnaire, according to the
prices set out below, depending on the languages requested and the costs of using the Questionnaire, in accordance with the
terms and conditions described in section 6.02 of the General Terms included in Appendix 1.

Commercial users

ROYALTY FEES*

Funded academic research

Not funded academic users

Commercial users
DISTRIBUTION
FEES*

Funded academic research

Not funded academic users

Cost per study

1 100€

Cost per language

550 €

Cost per study

Free

Cost per language

Free

Cost per study

Free

Cost per language

Free

Cost per study

1 000 €

Cost per language

500 €

Cost per study

300 €

Cost per language

50 €

Cost per study

Free

Cost per language

Free

Agreed and acknowledged by
Mott Brittany
30-Oct-2017
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APPENDIX F – PHOTO RELEASE FORMS

174

175

176

177

178

ABOUT THE AUTHOR
Brittany Mott is originally from Cocoa Beach, Florida. She graduated with her Bachelors
of Science in Industrial Engineering from University of South Florida (USF) in December 2016
and will graduate with her Masters of Science in Biomedical Engineering in May 2018. During
her time at USF, Ms. Mott has worked on countless projects with entities such as NASA and
Moffitt Cancer Center and has performed research at the Center for Assistive, Rehabilitation and
Robotics Technologies. Ms. Mott hopes to continue her efforts striving to improve human life
and performance within the medical industry.

